U.S. patent number 10,413,601 [Application Number 15/593,129] was granted by the patent office on 2019-09-17 for methods and compositions for the treatment of symptoms of prion diseases. This patent grant is currently assigned to Curemark, LLC. The grantee listed for this patent is Curemark, LLC. Invention is credited to Joan M. Fallon.
United States Patent | 10,413,601 |
Fallon | September 17, 2019 |
A therapeutic composition for the treatment of the symptoms of prion diseases and the method for preparing the therapeutic agents is disclosed. The therapeutic composition is a stable pharmaceutical composition comprising one or more digestive and/or pancreatic enzymes. The therapeutic composition may be manufactured by a variety of encapsulation technologies. Delivery of the therapeutic composition may be made orally, through injection, by adherence of a medicated patch or other method. Further, a method of using fecal chymotrypsin level as a biomarker for the presence of a prion disease, or the likelihood of an individual to develop a prion disease is disclosed.
Inventors: | Fallon; Joan M. (Rye, NY) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Applicant: |
|
||||||||||
Assignee: | Curemark, LLC (Rye,
NY) |
||||||||||
Family ID: | 42099041 | ||||||||||
Appl. No.: | 15/593,129 | ||||||||||
Filed: | May 11, 2017 |
Document Identifier | Publication Date | |
---|---|---|
US 20180078623 A1 | Mar 22, 2018 | |
Application Number | Filing Date | Patent Number | Issue Date | ||
---|---|---|---|---|---|
14713178 | May 15, 2015 | 9687535 | |||
13737225 | Jan 9, 2013 | 9061033 | |||
12573353 | Oct 5, 2009 | ||||
61102818 | Oct 3, 2008 | ||||
Current U.S. Class: | 1/1 |
Current CPC Class: | A61K 38/4873 (20130101); G01N 33/6896 (20130101); A61K 38/47 (20130101); A61K 38/4826 (20130101); A61K 38/54 (20130101); A61K 38/465 (20130101); C12Q 1/37 (20130101); A61K 36/185 (20130101); A61K 38/47 (20130101); A61K 2300/00 (20130101); A61K 38/4826 (20130101); A61K 2300/00 (20130101); A61K 38/465 (20130101); A61K 2300/00 (20130101); A61K 38/4873 (20130101); A61K 2300/00 (20130101); A61K 36/185 (20130101); A61K 2300/00 (20130101); C12Y 302/01 (20130101); G01N 2800/52 (20130101); C12Y 301/01 (20130101); G01N 2333/976 (20130101); C12Y 304/22002 (20130101); C12Y 304/21004 (20130101); G01N 2800/2828 (20130101); C12Y 304/00 (20130101); C12Y 304/21001 (20130101) |
Current International Class: | A61K 38/47 (20060101); G01N 33/68 (20060101); C12Q 1/37 (20060101); A61K 38/54 (20060101); A61K 38/46 (20060101); A61K 36/185 (20060101); A61K 38/48 (20060101) |
3002883 | October 1961 | Butt et al. |
3223594 | December 1965 | Hoek |
3322626 | May 1967 | D'Argento |
3357894 | December 1967 | Uriel et al. |
3515642 | June 1970 | Hiroyuki et al. |
3574819 | April 1971 | Franz et al. |
3860708 | January 1975 | Prout |
3940478 | February 1976 | Kurtz |
4079125 | March 1978 | Sipos |
4145410 | March 1979 | Sears |
4241046 | December 1980 | Papahadjopoulos et al. |
4280971 | July 1981 | Wischniewski et al. |
4447412 | May 1984 | Bilton |
4456544 | June 1984 | Lupova et al. |
4500515 | February 1985 | Libby |
4623624 | November 1986 | Schultze |
4826679 | May 1989 | Roy |
5023108 | June 1991 | Bagaria et al. |
5190775 | March 1993 | Klose |
5250418 | October 1993 | Moeller et al. |
5324514 | June 1994 | Sipos |
5378462 | January 1995 | Boedecker et al. |
5436319 | July 1995 | Kung et al. |
5437319 | August 1995 | Garuglieri |
5439935 | August 1995 | Rawlings et al. |
5460812 | October 1995 | Sipos |
5476661 | December 1995 | Pillai et al. |
5527678 | June 1996 | Blaser et al. |
5585115 | December 1996 | Sherwood et al. |
5607863 | March 1997 | Chandler |
5648335 | July 1997 | Lewis et al. |
5674532 | October 1997 | Atzl et al. |
5686311 | November 1997 | Shaw |
5750104 | May 1998 | Sipos |
5776917 | July 1998 | Blank et al. |
5858758 | January 1999 | Hillman et al. |
5952178 | September 1999 | Lapidus et al. |
5958875 | September 1999 | Longo et al. |
5977175 | November 1999 | Lin |
5985891 | November 1999 | Rowe |
6011001 | January 2000 | Navia et al. |
6013286 | January 2000 | Klose |
6020310 | February 2000 | Beck et al. |
6020314 | February 2000 | McMichael |
6096338 | August 2000 | Lacy et al. |
6100080 | August 2000 | Johansen |
6149585 | November 2000 | Gray |
6153236 | November 2000 | Wu et al. |
6168569 | January 2001 | McEwen et al. |
6187309 | February 2001 | McMichael et al. |
6197746 | March 2001 | Beck et al. |
6210950 | April 2001 | Johnson et al. |
6251478 | June 2001 | Pacifico et al. |
6261602 | July 2001 | Calanchi et al. |
6261613 | July 2001 | Narayanaswamy et al. |
6280726 | August 2001 | Weinrauch et al. |
6287585 | September 2001 | Johansen |
6309669 | October 2001 | Setterstrom et al. |
6399101 | June 2002 | Frontanes et al. |
6482839 | November 2002 | Thornfeldt |
6498143 | December 2002 | Beck et al. |
6534063 | March 2003 | Fallon |
6534259 | March 2003 | Wakefield |
6558708 | May 2003 | Lin |
6562629 | May 2003 | Lin et al. |
6569463 | May 2003 | Patel et al. |
6632429 | October 2003 | Fallon |
6660831 | December 2003 | Fallon |
6727073 | April 2004 | Moore et al. |
6743447 | June 2004 | Labergerie et al. |
6764447 | July 2004 | Iliff |
6783757 | August 2004 | Brudnak |
6790825 | September 2004 | Beck et al. |
6797291 | September 2004 | Richardson |
6808708 | October 2004 | Houston |
6821514 | November 2004 | Houston |
6827688 | December 2004 | Goto et al. |
6835397 | December 2004 | Lee et al. |
6852487 | February 2005 | Barany et al. |
6861053 | March 2005 | Lin et al. |
6890561 | May 2005 | Blatt et al. |
6899876 | May 2005 | Houston |
6923988 | August 2005 | Patel et al. |
6980958 | December 2005 | Surwit et al. |
7048906 | May 2006 | Lin et al. |
7081239 | July 2006 | Lin |
7091182 | August 2006 | Beck et al. |
7101573 | September 2006 | Szymczak et al. |
7122357 | October 2006 | Sander-Struckmeier et al. |
7129053 | October 2006 | Reiter et al. |
7138123 | November 2006 | Fallon |
7232670 | June 2007 | D'Azzo et al. |
7244412 | July 2007 | Lin |
7285633 | October 2007 | Wu et al. |
7381698 | June 2008 | Fein et al. |
7395216 | July 2008 | Rosenfeld et al. |
7479378 | January 2009 | Potthoff et al. |
7483747 | January 2009 | Gliner et al. |
7588757 | September 2009 | Ozawa et al. |
7608245 | October 2009 | Lin |
7630913 | December 2009 | Kay |
7658918 | February 2010 | Ortenzi et al. |
7718169 | May 2010 | Margolin et al. |
7736622 | June 2010 | Lin et al. |
7935799 | May 2011 | Lin et al. |
7945451 | May 2011 | Cosentino et al. |
8008036 | August 2011 | Fallon |
8012710 | September 2011 | Fallon |
8012930 | September 2011 | Fallon |
8030002 | October 2011 | Fallon |
8055516 | November 2011 | Iliff |
8066636 | November 2011 | Iliff |
8084025 | December 2011 | Fallon |
8105584 | January 2012 | Fallon |
8163278 | April 2012 | Fallon |
8211661 | July 2012 | Fallon |
8221747 | July 2012 | Ortenzi et al. |
8318158 | November 2012 | Fallon |
8437689 | May 2013 | Mazar |
8486390 | July 2013 | Fallon |
8580522 | November 2013 | Fallon |
8613918 | December 2013 | Fallon |
8658163 | February 2014 | Fallon |
8673877 | March 2014 | Fallon et al. |
8778335 | July 2014 | Fallon |
8815233 | August 2014 | Fallon |
8921054 | December 2014 | Fallon |
8980252 | March 2015 | Fallon et al. |
9017665 | April 2015 | Fallon |
9023344 | May 2015 | Fallon |
9056050 | June 2015 | Fallon et al. |
9061033 | June 2015 | Fallon |
9084784 | July 2015 | Fallon et al. |
9107419 | August 2015 | Fallon et al. |
9233146 | January 2016 | Fallon |
9320780 | April 2016 | Fallon |
9345721 | May 2016 | Fallon et al. |
9377459 | June 2016 | Fallon |
9408895 | August 2016 | Fallon |
9492515 | November 2016 | Fallon et al. |
9511125 | December 2016 | Fallon et al. |
9624525 | April 2017 | Fallon |
9624526 | April 2017 | Fallon |
1009884 | October 2018 | Fallon |
2001/0006644 | July 2001 | Bova et al. |
2001/0023360 | September 2001 | Nelson et al. |
2001/0024660 | September 2001 | Ullah et al. |
2002/0001575 | January 2002 | Foreman |
2002/0037284 | March 2002 | Fallon |
2002/0061302 | May 2002 | Sander-Struckmeier et al. |
2002/0081628 | June 2002 | Fallon |
2002/0090653 | July 2002 | Fallon |
2002/0094367 | July 2002 | Fuglsang et al. |
2002/0103675 | August 2002 | Vanelli |
2002/0119914 | August 2002 | Zhu et al. |
2002/0141987 | October 2002 | Bjarnason |
2002/0183229 | December 2002 | Simpson |
2003/0097122 | May 2003 | Ganz et al. |
2004/0005304 | January 2004 | Brudnak |
2004/0028689 | February 2004 | Borody |
2004/0029752 | February 2004 | Sava et al. |
2004/0057944 | March 2004 | Galle et al. |
2004/0057962 | March 2004 | Timmerman |
2004/0071683 | April 2004 | Fallon |
2004/0076590 | April 2004 | Wilkins |
2004/0101562 | May 2004 | Maio |
2004/0121002 | June 2004 | Lee et al. |
2004/0209790 | October 2004 | Sava et al. |
2005/0036950 | February 2005 | Jones et al. |
2005/0079594 | April 2005 | Marion |
2005/0137134 | June 2005 | Gill et al. |
2005/0170479 | August 2005 | Weaver et al. |
2005/0187130 | August 2005 | Brooker et al. |
2005/0232894 | October 2005 | Weiner et al. |
2006/0105379 | May 2006 | Wu et al. |
2006/0115467 | June 2006 | Pangborn et al. |
2006/0121017 | June 2006 | Margolin et al. |
2006/0182728 | August 2006 | Fallon |
2006/0183180 | August 2006 | Fallon |
2006/0198838 | September 2006 | Fallon |
2006/0258599 | November 2006 | Childers |
2006/0259995 | November 2006 | Cayouette et al. |
2007/0031399 | February 2007 | Edens et al. |
2007/0053895 | March 2007 | Fallon |
2007/0092501 | April 2007 | Houston |
2007/0116695 | May 2007 | Fallon |
2007/0148151 | June 2007 | Frink et al. |
2007/0148152 | June 2007 | Shlieout et al. |
2007/0148153 | June 2007 | Shlieout et al. |
2007/0203426 | August 2007 | Kover et al. |
2008/0019959 | January 2008 | Becher et al. |
2008/0020036 | January 2008 | Jolly |
2008/0057086 | March 2008 | Etter |
2008/0058282 | March 2008 | Fallon et al. |
2008/0112900 | May 2008 | Du-Thumm et al. |
2008/0112944 | May 2008 | Pangborn et al. |
2008/0152637 | June 2008 | Fallon |
2008/0161265 | July 2008 | Fallon et al. |
2008/0166334 | July 2008 | Fallon |
2008/0187525 | August 2008 | Porubcan |
2008/0199448 | August 2008 | Ross et al. |
2008/0219966 | September 2008 | Fallon |
2008/0248558 | October 2008 | Deinhammer et al. |
2008/0254009 | October 2008 | Finegold |
2008/0274174 | November 2008 | Ortenzi et al. |
2008/0279839 | November 2008 | Schuler et al. |
2008/0279953 | November 2008 | Ortenzi et al. |
2008/0311554 | December 2008 | Slotman |
2008/0317731 | December 2008 | Gramatikova et al. |
2009/0063402 | March 2009 | Hayter |
2009/0110674 | April 2009 | Loizou |
2009/0117180 | May 2009 | Ortenzi et al. |
2009/0130081 | May 2009 | Fallon |
2009/0197289 | August 2009 | Fallon |
2009/0226414 | September 2009 | Tijssen et al. |
2009/0232789 | September 2009 | Fallon |
2009/0233344 | September 2009 | Kurfurst et al. |
2009/0263372 | October 2009 | Fallon |
2009/0285790 | November 2009 | Fallon |
2009/0286270 | November 2009 | Fallon |
2009/0304670 | December 2009 | Edens et al. |
2009/0324572 | December 2009 | Fallon |
2009/0324730 | December 2009 | Fallon |
2010/0092447 | April 2010 | Fallon |
2010/0169409 | July 2010 | Fallon et al. |
2010/0196344 | August 2010 | Margolin et al. |
2010/0209507 | August 2010 | Lin et al. |
2010/0233218 | September 2010 | Fallon |
2010/0239559 | September 2010 | Freedman et al. |
2010/0260857 | October 2010 | Fallon et al. |
2010/0270183 | October 2010 | Ortenzi et al. |
2010/0285116 | November 2010 | Joshi |
2011/0029922 | February 2011 | Hoffberg et al. |
2011/0052706 | March 2011 | Moest et al. |
2011/0065628 | March 2011 | Johnson et al. |
2011/0081320 | April 2011 | Westall et al. |
2011/0112005 | May 2011 | Brooker et al. |
2011/0182818 | July 2011 | Fallon |
2011/0200574 | August 2011 | Jolly et al. |
2011/0280853 | November 2011 | Fallon et al. |
2011/0280854 | November 2011 | Fallon et al. |
2012/0003628 | January 2012 | Fallon |
2012/0004192 | January 2012 | Fallon et al. |
2012/0027848 | February 2012 | Fallon et al. |
2012/0070504 | March 2012 | Fallon |
2012/0128764 | May 2012 | Venkatesh et al. |
2012/0189703 | July 2012 | Fallon et al. |
2012/0201875 | August 2012 | Ortenzi et al. |
2012/0207740 | August 2012 | Fallon |
2012/0230970 | September 2012 | Fallon |
2013/0059001 | March 2013 | Fallon |
2013/0095152 | April 2013 | Fallon |
2013/0113129 | May 2013 | Fallon et al. |
2013/0195833 | August 2013 | Fallon |
2013/0202581 | August 2013 | Fallon et al. |
2013/0224172 | August 2013 | Fallon et al. |
2013/0323223 | December 2013 | Fallon et al. |
2014/0030333 | January 2014 | Fallon |
2014/0127184 | May 2014 | Fallon et al. |
2014/0147500 | May 2014 | Fallon et al. |
2014/0161787 | June 2014 | Fallon |
2014/0170637 | June 2014 | Fallon |
2014/0348881 | November 2014 | Fallon |
2015/0023944 | January 2015 | Fallon |
2015/0147308 | May 2015 | Fallon et al. |
2015/0150955 | June 2015 | Fallon et al. |
2015/0151198 | June 2015 | Dugan et al. |
2015/0174219 | June 2015 | Fallon |
2015/0182607 | July 2015 | Jolly et al. |
2015/0246104 | September 2015 | Fallon et al. |
2015/0246105 | September 2015 | Fallon et al. |
2015/0273030 | October 2015 | Fallon |
2015/0335589 | November 2015 | Fallon et al. |
2016/0045576 | February 2016 | Fallon et al. |
2016/0206708 | July 2016 | Fallon et al. |
2016/0213697 | July 2016 | Joan |
2016/0266113 | September 2016 | Joan |
2016/0287683 | October 2016 | Joan |
2017/0189501 | July 2017 | Fallon |
2017/0202934 | July 2017 | Fallon |
2017/0246265 | August 2017 | Fallon |
2018/0161409 | June 2018 | Fallon |
2018/0243282 | August 2018 | Fallon |
2018/0296650 | October 2018 | Fallon |
2198317 | Aug 1998 | CA | |||
2263703 | Aug 1999 | CA | |||
2667976 | May 2008 | CA | |||
2719102 | Sep 2009 | CA | |||
1031562 | Mar 1989 | CN | |||
1329923 | Jan 2002 | CN | |||
1552836 | Dec 2004 | CN | |||
1791430 | Jun 2006 | CN | |||
101039667 | Sep 2007 | CN | |||
101208092 | Jun 2008 | CN | |||
4332985 | Mar 1995 | DE | |||
202010004926 | Jul 2010 | DE | |||
0425214 | May 1991 | EP | |||
0436110 | Jul 1991 | EP | |||
0451484 | Oct 1991 | EP | |||
0564739 | Oct 1993 | EP | |||
0564739 | Apr 1995 | EP | |||
1162995 | Jun 2003 | EP | |||
1335706 | Apr 2005 | EP | |||
1019072 | May 2005 | EP | |||
1604677 | Dec 2005 | EP | |||
1931317 | Dec 2008 | EP | |||
2258837 | Dec 2010 | EP | |||
2318035 | May 2011 | EP | |||
2373791 | Oct 2011 | EP | |||
669782 | Apr 1952 | GB | |||
2347742 | Sep 2000 | GB | |||
2480772 | Nov 2011 | GB | |||
2506537 | Apr 2014 | GB | |||
S62230714 | Oct 1987 | JP | |||
H04364119 | Dec 1992 | JP | |||
2003517831 | Jun 2003 | JP | |||
2005515223 | May 2005 | JP | |||
2006512091 | Apr 2006 | JP | |||
2007523664 | Aug 2007 | JP | |||
2008283895 | Nov 2008 | JP | |||
20050084485 | Aug 2005 | KR | |||
2356244 | May 2009 | RU | |||
310277 | Jul 1997 | TW | |||
WO-8402846 | Aug 1984 | WO | |||
WO-8908694 | Sep 1989 | WO | |||
WO-9002562 | Mar 1990 | WO | |||
WO-9419005 | Sep 1994 | WO | |||
WO-9522344 | Aug 1995 | WO | |||
WO-9732480 | Sep 1997 | WO | |||
WO-9822499 | May 1998 | WO | |||
WO-9826807 | Jun 1998 | WO | |||
WO-9822499 | Jul 1998 | WO | |||
WO-9832336 | Jul 1998 | WO | |||
WO-9852593 | Nov 1998 | WO | |||
WO-9964059 | Dec 1999 | WO | |||
WO-0009142 | Feb 2000 | WO | |||
WO-9964059 | Mar 2000 | WO | |||
WO-0021504 | Apr 2000 | WO | |||
WO-0127612 | Apr 2001 | WO | |||
WO-0143764 | Jun 2001 | WO | |||
WO-0145835 | Jun 2001 | WO | |||
WO-0127612 | Oct 2001 | WO | |||
WO-0143764 | Nov 2001 | WO | |||
WO-0214537 | Feb 2002 | WO | |||
WO-0219828 | Mar 2002 | WO | |||
WO-0214537 | May 2002 | WO | |||
WO-02051352 | Jul 2002 | WO | |||
WO-02051436 | Jul 2002 | WO | |||
WO-03051345 | Jun 2003 | WO | |||
WO-03059088 | Jul 2003 | WO | |||
WO-2004060074 | Jul 2004 | WO | |||
WO-2004093883 | Nov 2004 | WO | |||
WO-2005115445 | Dec 2005 | WO | |||
WO-2006031554 | Mar 2006 | WO | |||
WO-2006044529 | Apr 2006 | WO | |||
WO-2006031554 | Sep 2006 | WO | |||
WO-2007002572 | Jan 2007 | WO | |||
WO-2007074454 | Jul 2007 | WO | |||
WO-2007147714 | Dec 2007 | WO | |||
WO-2008021987 | Feb 2008 | WO | |||
WO-2008102264 | Aug 2008 | WO | |||
WO-2009114757 | Sep 2009 | WO | |||
WO-2009155689 | Dec 2009 | WO | |||
WO-2010002972 | Jan 2010 | WO | |||
WO-2010025126 | Mar 2010 | WO | |||
WO-2010080830 | Jul 2010 | WO | |||
WO-2010080835 | Jul 2010 | WO | |||
WO-2010120781 | Oct 2010 | WO | |||
WO-2011000924 | Jan 2011 | WO | |||
WO-2011050135 | Apr 2011 | WO | |||
WO-2011114225 | Sep 2011 | WO | |||
WO-2012067621 | May 2012 | WO | |||
Medori et al.,The New England Journal of Medicine, 1992, vol. 326, No. 7, p. 444-449. cited by examiner . ABCNEWS. Changing Face of Autism: Numbers Rise as More Behaviors Included. ABCnews. Nov. 1, 2007. cited by applicant . Adams. Summary of Defeat Autism Now! (DNN!) Oct. 2001 Conference, retrieved from the internet Dec. 18, 2008. http://puterakembara.org/rm/DAN2001.htm. cited by applicant . Advisory Action dated Jun. 3, 2008 for U.S. Appl. No. 10/681,018. cited by applicant . Aman, et al. Outcome measures for clinical drug trials in autism. CNS Spectr. Jan. 2004;9(1):36-47. cited by applicant . Amendment and Response dated Apr. 7, 2010 in Reply to Restriction Requirement dated Oct. 7, 2009 for U.S. Appl. No. 12/283,090. cited by applicant . Amendment and Response dated Jun. 30, 2010 to Restriction Requirement dated Jan. 13, 2010 for U.S. Appl. No. 12/487,868. cited by applicant . Amendment dated Oct. 20, 2008 in Reply to Notice Non-responsive Amendment dated Sep. 22, 2008 for U.S. Appl. No. 11/232,180. cited by applicant . Amendment dated Oct. 24, 2008 in Reply to Notice of Non-Responsive Amendment dated Sep. 25, 2008 for U.S. Appl. No. 11/555,697. cited by applicant . Amendment dated Oct. 28, 2009 in Reply to Final Office Action dated Apr. 28, 2009 for U.S. Appl. No. 10/681,018. cited by applicant . Amendment dated Nov. 13, 2009 in Reply to Final Office Action dated Jul. 27, 2004 for U.S. Appl. No. 09/990,909. cited by applicant . Amendment dated Nov. 17, 2007 in Reply to Restriction Requirement dated Oct. 17, 2007 for U.S. Appl. No. 11/555,697. cited by applicant . Amendment dated Dec. 12, 2007 in Reply to Office Action dated Aug. 8, 2007 for U.S. Appl. No. 11/213,382. cited by applicant . Amendment dated Dec, 7, 2007 in Reply to Office Action dated Aug. 7, 2007 for U.S. Appl. No. 10/681,018. cited by applicant . Amendment dated Feb. 2, 2004 in Reply to Office Action dated Jul. 29, 2003 for U.S. Appl. No. 09/990,909. cited by applicant . Amendment dated Feb. 29, 2008 in Reply to Notice of Non-Responsive Amendment dated Feb. 11, 2008 for U.S. Appl. No. 11/555,697. cited by applicant . Amendment dated Feb. 7, 2003 in Reply to Office Action dated Jul. 30, 2002 for U.S. Appl. No. 09/990,909. cited by applicant . Amendment dated Feb. 7, 2009 in Reply to Office Action dated Aug. 18, 2008 for U.S. Appl. No. 10/681,018. cited by applicant . Amendment dated Mar. 1, 2004 in Reply to Office Action dated Aug. 26, 2003 for U.S. Appl. No. 10/041,073. cited by applicant . Amendment dated Mar. 24, 2010 in Reply to Final Office Action dated Sep. 24, 2009 for U.S. Appl. No. 12/046,252. cited by applicant . Amendment dated Mar. 3, 2008 to Restriction Requirement dated Jan. 10, 2008 for U.S. Appl. No. 11/232,180. cited by applicant . Amendment dated Mar. 4, 2008 in Reply to Office Action dated Nov. 14, 2007 for U.S. Appl. No. 11/213,255. cited by applicant . Amendment dated May 18, 2007 in Reply to Office Action dated Dec. 22, 2006 for U.S. Appl. No. 10/681,018. cited by applicant . Amendment dated May 19, 2008 in Reply to Final Office Action dated Mar. 17, 2008 for U.S. Appl. No. 10/681,018. cited by applicant . Amendment dated May 27, 2009 in Reply to Final Office Action dated Feb. 27, 2009 for U.S. Appl. No. 11/555,697. cited by applicant . Amendment dated Jun. 15, 2009 in Reply to Final Office Action dated Mar. 13, 2009 for U.S. Appl. No. 11/232,180. cited by applicant . Amendment dated Jun. 8, 2007 in Reply to Restriction Requirement dated May 9, 2007 for U.S. Appl. No. 11/213,382. cited by applicant . Amendment dated Jun. 8, 2010 in Reply to Office Action dated Jan. 8, 2010 for U.S. Appl. No. 10/681,018. cited by applicant . Amendment dated Jul. 2, 2008 in Reply to Notice of Non-Compliant Amendment dated Jun. 2, 2008 for U.S. Appl. No. 12/046,252. cited by applicant . Amendment dated Aug. 19, 2009 in Reply to Notice Non-Compliant Amendment dated Jun. 19, 2009 for U.S. Appl. No. 11/232,180. cited by applicant . Amendment dated Aug. 21, 2008 in Reply to Office Action dated Apr. 21, 2008 for U.S. Appl. No. 11/232,180. cited by applicant . Amendment dated Aug. 28, 2008 in Reply to Office Action dated Mar. 28, 2008 for U.S. Appl. No. 11/555,697. cited by applicant . Amendment dated Sep. 24, 2007 in Reply to Restriction Requirement dated Jun. 22, 2007 for U.S. Appl. No. 11/213,255. cited by applicant . Amendment dated Sep. 25, 2008 in Reply to Final Office Action dated Jun. 25, 2008 for U.S. Appl. No. 11/213,255. cited by applicant . Amendment in Response dated May 23, 2003 to Restriction Requirement dated Apr. 23, 2003 for U.S. Appl. No. 09/990,909. cited by applicant . Ang, et al. Biological role and regulation of the universally conserved heat shock proteins. J Biol Chem. Dec. 25, 1991;266(36):24233-6. cited by applicant . APDA. Basic Information About Parkinson's Disease. Jul. 14, 2008. cited by applicant . Arribas, et al. A comparative study of the chymotrypsin-like activity of the rat liver multicatalytic proteinase and the CIpP from Escherichia coli. J Biol Chem. Oct. 5, 1993;268(28):21165-71. cited by applicant . Arrigo, et al. Expression of heat shock proteins during development in Drosophila. Results Probl Cell Differ. 1991;17:106-19. cited by applicant . Ash. Patient Information Guide--Understanding Hypertension. American Society of Hypertension. 2004. 1-7. cited by applicant . Ashwood, et al. Immune activation of peripheral blood and mucosal CD3+ lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms. J Neuroimmunol. Dec. 19, 2005; 1-9. cited by applicant . Ashwood, et al. Intestinal lymphocyte populations in children with regressive autism: evidence for extensive mucosal immunopathology. J Clin Immunol. Nov. 2003;23(6):504-17. cited by applicant . Ashwood, et al. Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10. J Clin Immunol. Nov. 2004;24(6):664-73. cited by applicant . Austic. Development and adaptation of protein digestion. J Nutr. May 1985;115(5):686-97. cited by applicant . Autism Diagnosis. Autism Statistics. Www.autism-diagnosis.com/autism_statistics/autism_statistics.html. 2007. cited by applicant . Autism Society of America. Incidence Numbers from Other Countries. www.autism-society.org. Accessed: Jul. 14, 2008. cited by applicant . Awazuhara, et al. Antigenicity of the proteins in soy lecithin and soy oil in soybean allergy. Clin Exp Allergy. Dec. 1998;28(12):1559-64. cited by applicant . Axcan Pharma Inc. Cdn Prescribing Information on VIOKASE Pancrelipase, USP tablets, powder. 2000: 1-3. cited by applicant . Axelrod. Secretin Treatment for Gastrointestinal Dysmobility in Patients with Familial Dysautonomia. New York University School of Medicine, Grant Recipient awards, Mar.-May 2000. www.med.nyu.edu/ogars/awards/awards2000/page2.html. cited by applicant . Azilect et al. Correlation between protein intake and daily levodopa dosage, Obtained from the internet May 2, 2007, http://www.azilect.eu/media/cnsnews/showitem.aspx?i=d1c603e4-3c61-4aa1-a3- 76-6e519a5a0f80. cited by applicant . Bailey, et al. Co-occurring conditions associated with FMR1 gene variations: findings from a national parent survey. Am J Med Genet A. Aug. 15, 2008;146A(16):2060-9. cited by applicant . Bakkaloglu, et al. Atopic features in early childhood autism. Eur J Paediatr Neurol. Nov. 2008;12(6):476-9. cited by applicant . Barlow. A comparison of the blood pressure, kidney volume and the pancreatic secretory response following the vein administration of various secretin preparations. Am J Phys. 1927;81:182-188. cited by applicant . Barnhart, et al. Symptomatic granular cell tumor involving the pituitary gland in a dog: a case report and review of the literature. Vet Pathol. May 2001;38(3):332-6. cited by applicant . Beilmann, et al. Neoexpression of the c-met/hepatocyte growth factor-scatter factor receptor gene in activated monocytes. Blood. Dec. 1, 1997;90(11):4450-8. cited by applicant . Bellanti, et al. Abnormalities of Th1 function in non-IgE food allergy, celiac disease, and ileal lymphonodular hyperplasia: a new relationship? Ann Allergy Asthma Immunol. Jun. 2003;90(6 Suppl 3):84-9. cited by applicant . Belmonte et al. Fragile X syndrome and autism at the intersection of genetic and neural networks. Nat Neurosci. Oct. 2006; 9(10):1221-5 (abstract only). cited by applicant . Berg, et al. Section 10.5 Many Enzymes Are Actived by Specific Proteolytic Cleavage. 2002. cited by applicant . Berg, et al. Section 9.1 Proteases: Facilitating a Difficult Reaction. 2002. cited by applicant . Berg, et al. Table of Contents. Biochemistry, 5th edition. 2002. cited by applicant . Birnbaum, et al. Heat shock or stress proteins and their role as autoantigens in multiple sclerosis. Ann N Y Acad Sci. Dec. 19, 1997;835:157-67. Abstract only. cited by applicant . Blackmer. Parkinson disease: treatment and medication. Mar. 10, 2009, retrieved from the internet on Sep. 15, 2009, http://emedicine.medscape.com/article/312519-treatment. cited by applicant . Block, et al. A rapid food screener to assess fat and fruit and vegetable intake. Am J Prev Med. May 2000;18(4):284-8. cited by applicant . Blog. Acid Phosphatase Research (blog). Acid-phosphatase.blogspot.com. 2008. cited by applicant . Bode et al. Usefulness of a simple photometric determination of chymotrypsin activity in stools--results of a multicentre study. Clin Biochem. 1986; 19:333-37. cited by applicant . Boorom. Is this recently characterized gastrointestinal pathogen responsible for rising rates of inflammatory bowel disease (IBD) and IBD associated autism in Europe and the United States in the 1990s? Med Hypotheses. 2007;69(3):652-9. cited by applicant . Borlongan. Recent preclinical evidence advancing cell therapy for Alzheimer's disease. Exp Neurol. Sep. 2012;237(1):142-6. doi: 10.1016/j.expneurol.2012.06.024. Epub Jun. 27, 2012. cited by applicant . Borowitz et al., Study of a novel pancreatic enzyme replacement therapy in pancreatic insufficient subjects with cystic fibrosis J.Pediatr., 149:658-662 (2006). cited by applicant . Borowitz, et al. Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. Consensus Committee. J Pediatr. Nov. 1995;127(5):681-4. cited by applicant . Bowen. Exocrine secretions of the pancreas. Jul. 5, 2006. Accessed online at www.vivo.colostate.edu/hbooks/pathphys/digestion/pancreas/exocrine.htm- l. cited by applicant . Boyd, et al. Positively charged amino acid residues can act as topogenic determinants in membrane proteins. Proc Natl Acad Sci U S A. Dec. 1989;86(23):9446-50. cited by applicant . Bradstreet, et al. Detection of Measles Virus Genomic RNA in Cerebrospinal Fluid of Children with Regressive Autism: a Report of Three Cases. J. Am Phys Surg. 2004; 9(2):38-45. cited by applicant . Bray, et al. Effect of dietary protein content on weight gain, energy expenditure, and body composition during overeating. A randomized controlled trial. JAMA. Jan. 4, 2012; 307(1):47-55. cited by applicant . Brinkley, et al. Factor analysis of the aberrant behavior checklist in individuals with autism spectrum disorders. J Autism Dev Disord. Nov. 2007;37(10):1949-59. Epub Dec. 21, 2006. cited by applicant . Brown. Background to Parkinson's Disease. biomed.brown.edu. Jul. 14, 2008. cited by applicant . Brudnak et al. Enzyme-based therapy for autism spectrum disorders--is it worth another look? Med Hypoth. 2002; 58:422-428. cited by applicant . Brudnak, Mark et al., Guide to intestinal health in autism spectrum disorder, Kirkman Laboratories, (Oct. 2001). cited by applicant . Bruhat, et al. Amino acid limitation induces expression of CHOP, a CCAAT/enhancer binding protein-related gene, at both transcriptional and post-transcriptional levels. J Biol Chem. Jul. 11, 1997;272(28):17588-93. cited by applicant . Calderon-Garciduenas, et al. Immunotoxicity and environment: immunodysregulation and systemic inflammation in children. Toxicol Pathol. 2009;37(2):161-9. cited by applicant . Caldwell, et al. Crystalline Pancreatic Amylase. II. Improved Method for its Preparation from Hog Pancreas Glands and Additional Studies of its Properties. J. Am. Chem. Soc. 1952; 74(16):4033-4035. cited by applicant . Campbell et al. A genetic variant that disrupts MET transcription is associated with autism. Proc Natl Acad Sci USA. 2006; 103(45):16834-16839. cited by applicant . Campbell, et al. Distinct genetic risk based on association of MET in families with co-occurring autism and gastrointestinal conditions. Pediatrics. Mar. 2009;123(3):1018-24. cited by applicant . Carlton. Autism and malnutrition: the milk connection. Retrieved from the internet on Feb. 18, 2008, http://www.mercola.com/2004/autism_malnutrition.htm. cited by applicant . Caronna, et al. Autism spectrum disorders: clinical and research frontiers. Arch Dis Child. Jun. 2008;93(6):518-23. cited by applicant . Carroccio, et al. Pancreatic enzyme therapy in childhood celiac disease. A double-blind prospective randomized study. Dig Dis Sci. Dec. 1995;40(12):2555-60. cited by applicant . Carroccio, et al. Secondary impairment of pancreatic function as a cause of severe malabsorption in intestinal giardiasis: a case report. Am J Trop Med Hyg. Jun. 1997;56(6):599-602. cited by applicant . Carroccio, et al. Secretin-cerulein test and fecal chymotrypsin concentration in children with intestinal giardiasis. Int J Pancreatol. Oct. 1993;14(2):175-80. cited by applicant . Cassidy, et al. A new concept for the mechanism of action of chymotrypsin: the role of the low-barrier hydrogen bond. Biochemistry. Apr. 15, 1997;36(15):4576-84. cited by applicant . CDC. Attention-Deficit/Hyperactivity Disorder (ADHD). Www.cdc.org. 2005. cited by applicant . CDC. Autism Information Center/FAQs. Dept of Health and Human Services/CDC. Jan. 30, 2008. cited by applicant . CDC, Escherichia coli, Travelers Health, Chapter 3: Infectious Diseases Related to Travel, Jul. 10, 2015, Available Online at: wwwnc.cdc.gov/travel/yellowbook/2016/infectious-diseases-related-to-trave- l/escherichia-coli. cited by applicant . CDC. High Blood Pressure. Division for Heart Disease Stroke Prevention. Jul. 15, 2003. cited by applicant . Chazalette, J.P. et al., A double-bind placebo-controlled trial of a pancreatic enzyme formulation (Panzytrat 25000) in the treatment of impaired lipid digestion in patients with cystic fibrosis. Drug Invest., 5(5):274-280 (1993). cited by applicant . Chen, et al. Identification of two lysosomal membrane glycoproteins. J Cell Biol. Jul. 1985;101(1):85-95. cited by applicant . Chen, et al. Lysine 43 is trimethylated in subunit C from bovine mitochondrial ATP synthase and in storage bodies associated with batten disease. J Biol Chem. May 21, 2004;279(21):21883-7. cited by applicant . Chen, et al. Medicinal Functions of Bromelain and Its Application Prospect in Animal Husbandry, China Animal Husbandry & Veterinary Medicine. 2005; vol. 32, No. 1, p. 14-16. (in Chinese with English translation). cited by applicant . Childhood Autism Rating Scale (CARS), Wikipedia, downloaded May 5, 2014. cited by applicant . Cichoke, AJ The Complete Book of Enzyme Therapy, Penguin (1999) pp. 206-208 and 38. cited by applicant . Cichoke. Celiac disease. The complete book of enzyme therapy. Penguin. New York, NY. 1999; 174-177. cited by applicant . Cichoke, et al. The complete book of enzyme therapy. Penguin. 1998: 39, 42, 47, 50, and 53. cited by applicant . Cichoke. Influenza. In: The Complete Book of Enzyme Therapy. D. Stewart, ed. Copyright 1999. Anthony J. Cichoke. Penquin Putnam, Inc., New York, New York. pp. Contents, 50, 273-275 and 455. cited by applicant . Claud, et a. Hypothesis: inappropriate colonization of the premature intestine can cause neonatal necrotizing enterocolitis. FASEB J. Jun. 2001;15(8):1398-403. cited by applicant . Cohn. Optimizing the Effectiveness of Pancreatic Enzyme Replacement Therapy (PERT). Clinical Impressions. Sep. 1, 2009; 1-4. cited by applicant . Commentary on the Japanese Pharmacopoeia, 14th ed., D929-D931, 2001. cited by applicant . Concerta. ADHD Myths and Facts. ADHD Myths and Facts about medication, girls, and symptoms and causes. Concerta.net. Jul. 15, 2008. cited by applicant . Co-pending U.S. Appl. No. 15/440,942, filed Feb. 23, 2017. cited by applicant . Corring, et al. Development of digestive enzymes in the piglet from birth to 8 weeks. I. Pancreas and pancreatic enzymes. Nutr Metab. 1978;22(4):231-43. cited by applicant . Couet, et al. Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem. Mar. 7, 1997;272(10):6525-33. cited by applicant . Coyle. Treating the Negative Symptoms of Schizophrenia: An Expert Interview with Joseph Coyle, MD. www.narsad.org/?q=node/438/latest-research. 2006. cited by applicant . Craig, et al. Heat shock proteins: molecular chaperones of protein biogenesis. Microbiol Rev. Jun. 1993;57(2):402-14. cited by applicant . Creon--FDA Prescribing information side effects and uses. Revised Apr. 2015. cited by applicant . Creon digestive enzymes. Celic.com/ Jun. 2009. http://www.celiac.com/gluten-free/topic/59195-creon-digestive-enzymes. cited by applicant . Creon. Full prescribing information. Last edited Mar. 2013. Abbvie Inc 2012. www.rxabbvie.com/pdf/creon_PI.pdf. cited by applicant . Croonenberghs, et al. Peripheral markers of serotonergic and noradrenergic function in post-pubertal, caucasian males with autistic disorder. Neuropsychopharmacology. Mar. 2000;22(3):275-83. cited by applicant . Cruse et al. Illustrated dictionary of immunology. CRC Press, New York. 1995. cited by applicant . Cuervo, et al. Cathepsin A regulates chaperone-mediated autophagy through cleavage of the lysosomal receptor. EMBO J. Jan. 2, 2003;22(1):47-59. cited by applicant . Curemark press release. Curemark Receives Investigational New Drug Clearance for CM-AT for Autism. Mar. 26, 2009. http://www.medicalnewstoday.com/releases/143723.php. cited by applicant . Dajcs, et al. Lysostaphin is effective in treating methicillin-resistant Staphylococcus aureus endophthalmitis in the rabbit. Curr Eye Res. Jun. 2001;22(6):451-7. cited by applicant . Darman. An introduction to alternative medicine for psychiactric conditions. Oct. 22, 2007, retrieved on Sep. 18, 2009, http://web.archive.org/web/20071022104238/http://altp[therapies4bipolar.i- nfo/ortho/html. cited by applicant . Dawe, et al. The chakragati mouse: a mouse model for rapid in vivo screening of antipsychotic drug candidates. Biotechnol J. Nov. 2007;2(11):1344-52. cited by applicant . Dawn. Autism: the Latest Prevalence Rates in USA--Now 1 in 175. Disabled Women's Network Ontario. Dawn.thot.net/autism2.html. 2006. cited by applicant . Dawson lab. Research Projects in Synthetic Protein Chemistry. 2005; 1-2. cited by applicant . Delong. News on Parkinson's. The Dana Foundation. Jul. 14, 2008. cited by applicant . Derwent. English abstract for RU 2286785 Nov. 10, 2006. Downloaded from the Derwent file Jul. 13, 2011. cited by applicant . Diaz-Hernandez, et al. Neuronal induction of the immunoproteasome in Huntington's disease. J Neurosci. Dec. 17, 2003;23(37):11653-61. cited by applicant . Digestive Enzyme Preparation: Pancreatin listed in Japanese Pharmacopoeia, Aug. 2008,<URL:http:>(in Japanese with English translation)</URL:http:>. cited by applicant . Digestive Enzyme Wikipedia. Retrieved from the internet Sep. 10, 2009, http://en.wikipedia.org/wiki/Digestive_enzyme. cited by applicant . Ding, et al. Proteasome inhibition in oxidative stress neurotoxicity: implications for heat shock proteins. J Neurochem. May 2001;77(4):1010-7. cited by applicant . Dobbs et al. Link between helicobacter pylori infection and idiopathic parkinsonism. Medical Hypothsis. 2000; 55(2):93-98. cited by applicant . Dockter et al. Determination of chymotrypsin in the feces by a new photometric method. Padiatr Padol. 1985; 20(3):257-265. cited by applicant . Dominquez-Munoz, et al. Optimising the therapy of exocrine pancreatic insufficiency by the association of a proton pump inhibitor to enteric coated pancreatic extracts. Gut. Jul. 2006;55(7):1056-7. cited by applicant . Dupiereux, et al. Creutzfeldt-jakob, Parkinson, lewy body dementia and Alzheimer diseases: from diagnosis to therapy. Cent Nerv Syst Agents Med Chem. Mar. 2009;9(1):2-11. cited by applicant . Eaves, et al. The criterion-related validity of the Childhood Autism Rating Scale and the Autism Behavior Checklist. J Abnorm Child Psychol. Oct. 1993;21(5):481-91. abstract only. cited by applicant . Edelson, et al. 3-Cyclohexene-1-glycine, an Isoleucine Antagonist. J. Am. Chem. Soc. 1958; 80(11):2698-2700. cited by applicant . Elkashef, et al. Biological markers of cocaine addiction: implications for medications development. Addict Biol. Jun. 2003;8(2):123-39. cited by applicant . Elphick, et al. Impaired luminal processing of human defensin-5 in Crohn's disease: persistence in a complex with chymotrypsinogen and trypsin. Am J Pathol. Mar. 2008;172(3):702-13. cited by applicant . Emc, Creon 10000 Capsules, May 18, 2015, Available Online at: www.medicines.org.uk/emc/medicine/2068. cited by applicant . eMedExpert, Antibiotics:Cephalosporins, Available online at: www.emedexpert.com/compare/cephalosporins.shtml, available as early as Jun. 2, 2007 per Internet Archive Wayback Machine. cited by applicant . Ethridge, et al. Acute pancreatitis results in induction of heat shock proteins 70 and 27 and heat shock factor-1. Pancreas. Oct. 2000;21(3):248-56. cited by applicant . European Application No. 15 200616.9 Extended Search Report dated Jun. 22, 2016. cited by applicant . Evans, et al. Pancreatic insufficiency in adult celiac disease: do patients require long-term enzyme supplementation? Dig Dis Sci. Oct. 2010;55(10):2999-3004. doi: 10.1007/s10620-010-1261-y. Epub May 11, 2010. cited by applicant . Exocrine Pancreatic Insufficiency (Enzymes) Document downloaded online on Jan. 8, 2016 at: http://www.epi4dogs.com/enzyme.htm< http:></http:>. cited by applicant . Fafournoux, et al. Amino acid regulation of gene expression. Biochem J. Oct. 1, 2000;351(Pt 1):1-12. cited by applicant . Fallingborg, et al. Measurement of gastrointestinal pH and regional transit times in normal children. J Pediatr Gastroenterol Nutr. Aug. 1990;11(2):211-4. cited by applicant . Fallon. Could one of the most widely prescribed antibiotics amoxicillin/clavulanate augmentin be a risk factor for autism? Med Hypotheses. 2005;64(2):312-5. cited by applicant . Family Caregiver Alliance. Fact Sheet: Parkinson's Disease. Caregiver.org. Jul. 14, 2008. cited by applicant . Fernell, et al. No evidence for a clear link between active intestinal inflammation and autism based on analyses of faecal calprotectin and rectal nitric oxide. Acta Paediatr. Jul. 2007;96(7):1076-9. cited by applicant . Ferrone, et al. Pancreatic enzyme pharmacotherapy. Pharmacotherapy. 2007; 27:910-920. cited by applicant . Fido, et al. Olanzapine in the treatment of behavioral problems associated with autism: an open-label trial in Kuwait. Med Princ Pract. 2008;17(5):415-8. doi: 10.1159/000141508. Epub Aug. 6, 2008. cited by applicant . Filipek et al. The screening and diagnosis of autistic spectrum disorders. J. of Autism and Dev Disorders. 1999; 29(6). cited by applicant . Final Office Action dated Jan. 3, 2012 for U.S. Appl. No. 10/681,018. cited by applicant . Final Office Action dated Jan. 26, 2012 for U.S. Appl. No. 12/487,864. cited by applicant . Final Office Action dated Nov. 8, 2011 for U.S. Appl. No. 12/054,343. cited by applicant . Final Office Action dated Nov. 8, 2011 for U.S. Appl. No. 12/786,739. cited by applicant . Final Office Action dated Nov. 9, 2010 for U.S. Appl. No. 09/990,909. cited by applicant . Final Office Action dated Feb. 14, 2011 for U.S. Appl. No. 12/049,613. cited by applicant . Final Office Action dated Feb. 27, 2009 for U.S. Appl. No. 11/555,697. cited by applicant . Final Office Action dated Mar. 13, 2009 for U.S. Appl. No. 11/232,180. cited by applicant . Final Office Action dated Mar. 17, 2008 for U.S. Appl. No. 10/681,018. cited by applicant . Final Office Action dated Apr. 28, 2009 for U.S. Appl. No. 10/681,018. cited by applicant . Final Office Action dated May 11, 2010 for U.S. Appl. No. 11/555,697. cited by applicant . Final Office Action dated Jun. 25, 2008 for U.S. Appl. No. 11/213,255. cited by applicant . Final Office Action dated Jul. 2, 2010 for U.S. Appl. No. 12/046,252. cited by applicant . Final Office Action dated Jul. 27, 2004 for U.S. Appl. No. 09/990,909. cited by applicant . Finegold et al. Gastrointestinal microflora studies in late-onset autism. Clinical Infectious Diseases. 2002; 35(1):S6-S15. cited by applicant . Fitzsimmons, et al. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. N Engl J Med. May 1, 1997;336(18):1283-9. cited by applicant . Fliri, et al. Drug effects viewed from a signal transduction network perspective. J Med Chem. Dec. 24, 2009;52(24):8038-46. doi: 10.1021/jm901001p. cited by applicant . Frossard, et al. Both thermal and non-thermal stress protect against caerulein induced pancreatitis and prevent trypsinogen activation in the pancreas. Gut. Jan. 2002;50(1):78-83. cited by applicant . Frossard. Trypsin activation peptide (TAP) in acute pancreatitis: from pathophysiology to clinical usefulness. JOP. Mar. 2001;2(2):69-77. cited by applicant . Furlano, et al. Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism. J Pediatr. Mar. 2001;138(3):366-72. cited by applicant . Garcia et al. Detection of giardia lamblia, entamoeba histolytica/entamoeba dispar, and cryptosporidium parvum antigens in human fecal specimens using the triage parasite panel enzyme immunoassay. Am Soc for Microbiology. 2000; 38(9):3337-3340. cited by applicant . Gardner. Absorption of intact peptides: studies on transport of protein digests and dipeptides across rat small intestine in vitro. Q J Exp Physiol. Oct. 1982;67(4):629-37. cited by applicant . Garner Jr, et al. Porcine Pancreatic Lipase--A Glycoprotein. J Biol Chem. Jan. 25, 1972;247(2):561-5. cited by applicant . Gass, et al. Enhancement of dietary protein digestion by conjugated bile acids. Gastroenterology. Jul. 2007;133(1):16-23. cited by applicant . Generation Rescue. Autism and Vaccines Around the World: Vaccine Schedules, Autism Rates, and Under 5 Mortality. Apr. 1, 2009. cited by applicant . Giglio, et al. Failure to thrive: the earliest feature of cystic fibrosis in infants diagnosed by neonatal screening. Acta Paediatr. Nov. 1997;86(11):1162-5. cited by applicant . GM Chemie 2010 Products: Hypromellose Phthalate accessed from www.gmchemie.com on Sep. 22, 2014. cited by applicant . Goff, et al. Production of abnormal proteins in E. coli stimulates transcription of Ion and other heat shock genes. Cell. Jun. 1985;41(2):587-95. cited by applicant . Gonzalez, et al. Endoscopical, histological and immunological characteristics of the digestive mucosa in autistic children with gastrointestinal symptoms. 2005; 1-7. cited by applicant . Green, et al. Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry. Aug. 16, 1994;33(32):9414-9. cited by applicant . Gupta, et al. Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism. J Neuroimmunol. May 1, 1998;85(1):106-9. cited by applicant . Hadjivassiliou, et al. Does cryptic gluten sensitivity play a part in neurological illness? Lancet. Feb. 10, 1996;347(8998):369-71. cited by applicant . Happe et al. The neuropsychology of autism. Brain. 1996; 119:1377-1400. cited by applicant . Happe et al. Time to give up on a simple explanation for autism. Nat Neurosci. Oct. 2006; 9(10):1218-20. cited by applicant . Health.com. Who is affected by Parkinson's disease. www.health.com. Jul. 14, 2008. cited by applicant . Heijerman, et al. Omeprazole enhances the efficacy of pancreatin (pancrease) in cystic fibrosis. Ann Intern Med. Feb. 1, 1991;114(3):200-1. cited by applicant . Hendren et al. Mechanistic biomarkers for autism treatment. Medical Hypotheses. 2009; 73:950-954. cited by applicant . Hitti. Allergy, celiac disease, and ileal lymphonodular. WebMD. 2005. 1-2. cited by applicant . Holquist et al. FDA safety page: Delayed-release vs. extended release Rxs. Drug Topics [online] Jul. 23, 2007 [Retrieved on Jul. 30, 2012] Retrieved from the internet: http://drugtopics.modernmedicine.com/drugtopics/Top+News/FDA-safety-page-- Delayed-release-vs-extended-release/ArticleStandard/Article/detail/442606. cited by applicant . Holten, et al. Appropriate prescribing of oral beta-lactam antibiotics. Am Fam Physician. Aug. 1, 2000;62(3):611-20. cited by applicant . Horvath, et al. Autism and gastrointestinal symptoms. Curr Gastroenterol Rep. Jun. 2002;4(3):251-8. cited by applicant . Horvath, et al. Autistic disorder and gastrointestinal disease. Curr Opin Pediatr. Oct. 2002;14(5):583-7. cited by applicant . Horvath, et al. Gastrointestinal abnormalities in children with autistic disorder. J Pediatr. Nov. 1999;135(5):559-63. cited by applicant . Horvath et al. Improved social and language skills after secretin administration in patients with autistic spectrum disorders. Journal of the Association for Academic Minority Physicians. Jan. 1998; 9(1):9-15. cited by applicant . Hoshiko et al. The effect of the gastrointestinal hormones on colonic muscosal blood flow. Acta Medica Nagasakiensia. 1994; 39(4):125-130. cited by applicant . Houston. Autism--One Conference. May 2006. 1-83. cited by applicant . Hsiao, et al. The microbes of the intestine: an introduction to their metabolic and signaling capabilities. Endocrinol Metab Clin North Am. Dec. 2008;37(4):857-71. cited by applicant . Huang, et al. Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases. Hum Mol Genet. Oct. 1997;6(11):1879-85. cited by applicant . Huang, et al. Mapping of the human APOB gene to chromosome 2p and demonstration of a two-allele restriction fragment length polymorphism. Proc Natl Acad Sci U S A Feb. 1986;83(3):644-8. cited by applicant . Information of Papain from Worthington Enzymes webpage http://www.worthington-biochem.com/pap/default.html Downloaded Jan. 17, 2013. cited by applicant . International preliminary report on patentability dated Jul. 17, 2014 for PCT/US2013/020183. cited by applicant . International search report and written opinion dated Feb. 21, 2013 for PCT/US2013/020183. cited by applicant . International search report and written opinion dated May 9, 2013 for PCT/US2013/024453. cited by applicant . International search report and written opinion dated Aug. 27, 2013 for PCT/US2013/043444. cited by applicant . International search report and written opinion dated Nov. 12, 2012 for PCT/US2012/034489. cited by applicant . International search report and written opinion dated Jan. 18, 2011 for PCT/US2010/057341. cited by applicant . International search report and written opinion dated Feb. 15, 2011 for PCT/US2010/053484. cited by applicant . International search report and written opinion dated Mar. 2, 2010 for PCT/US2010/020253. cited by applicant . International search report and written opinion dated Jun. 9, 2010 for PCT/US2010/030895. cited by applicant . International search report and written opinion dated Sep. 25, 2009 for PCT/US2009/049374. cited by applicant . International search report and written opnion dated Mar. 5, 2010 for PCT/US2010/020259. cited by applicant . International search report dated Mar. 11, 2002 for PCT/US2001/25343. cited by applicant . International search report dated Jun. 29, 2001 for PCT/US2000/34000. cited by applicant . Isaksson, et al. Pain reduction by an oral pancreatic enzyme preparation in chronic pancreatitis. Digestive Dis. Sci. 1983; 28(2):97-102. cited by applicant . James, et al. Thimerosal neurotoxicity is associated with glutathione depletion: protection with glutathione precursors. Neurotoxicology. 2004; 26(1):1-8. cited by applicant . Jeffrey. Global burden of hypertension may reach 1.5 billion by 2025. Medscape Medical News. Jul. 14, 2008. cited by applicant . Jenkins, et al. Management of gastroenteritis. Archives of Disease in Childhood. 1990; 65:939-941. cited by applicant . Juhl. Fibromyalgia and the serotonin pathway. Altern Med Rev. 1998; 3(5):367-375. cited by applicant . Jyonouchi, et al. Dysregulated innate immune responses in young children with autism spectrum disorders: their relationship to gastrointestinal symptoms and dietary intervention. Neuropsychobiology. 2005;51(2):77-85. cited by applicant . Jyonouchi, et al. Evaluation of an association between gastrointestinal symptoms and cytokine production against common dietary proteins in children with autism spectrum disorders. J Pediatr. May 2005;146(5):605-10. cited by applicant . Jyonouchi, et al. Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J Neuroimmunol. Nov. 1, 2001;120(1-2):170-9. cited by applicant . Kachrimanis, et al. Tensile strength and disintegration of tableted silicified microcrystalline cellulose: influences of interparticle bonding. J Pharm Sci. Jul. 2003;92(7):1489-501. cited by applicant . Kaemmerer, et al. Effects of lipid peroxidation-related protein modifications on RPE lysosomal functions and POS phagocytosis. Invest Ophthalmol Vis Sci. Mar. 2007;48(3):1342-7. cited by applicant . Kaminski, et al. Polymorphism of bovine beta-casein and its potential effect on human health. J Appl Genet. 2007;48(3):189-98. cited by applicant . Kaspar et al. New photometric assay for chymotrypsin in stool. Clinical Chemistry. 1984; 30(11):1753-1757. cited by applicant . Kearney, et al. Global burden of hypertension: analysis of worldwide data. Lancet. Jan. 15-21, 2005;365(9455):217-23. Abstract only. cited by applicant . King, et al. Effects of bacterial microflora of the lower digestive tract of free-range waterfowl on influenza virus activation. Appl Environ Microbiol. Jun. 2011;77(12):4119-25. doi: 10.1128/AEM.02578-10. Epub Apr. 29, 2011. cited by applicant . Knivsberg, et al. A randomised, controlled study of dietary intervention in autistic syndromes. Nutr Neurosci. Sep. 2002;5(4):251-61. cited by applicant . Kokai-Kun, et al. Lysostaphin as a treatment for systemic Staphylococcus aureus infection in a mouse model. J Antimicrob Chemother. Nov. 2007;60(5):1051-9. Epub Sep. 10, 2007. cited by applicant . Koller, et al. Falls and Parkinson's Disease (Abstract). Clin Neuropharmacol. 1989; 12(2):98-105. cited by applicant . Koplin, et al. Soy consumption is not a risk factor for peanut sensitization. J Allergy Clin Immunol. Jun. 2008;121(6):1455-9. cited by applicant . Koster et al. Evidence based medicine and extradigestive manifestations of helocobacter pylori. Acta Gastro-Enterologica Belgica. 2000; 63(4):388-392. cited by applicant . Krishnaswami, et al. A systematic review of secretin for children with autism spectrum disorders. Pediatrics. May 2011;127(5):e1322-5. doi: 10.1542/peds.2011-0428. Epub Apr. 4, 2011. cited by applicant . Kronenberg, et al. Folate deficiency induces neurodegeneration and brain dysfunction in mice lacking uracil DNA glycosylase. J Neurosci. Jul. 9, 2008;28(28):7219-30. cited by applicant . Kujoth, et al. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science. Jul. 15, 2005;309(5733):481-4. cited by applicant . Larimore. How Common Is ADHD? Facts About ADHD. Jul. 15, 2008. cited by applicant . Lashkari, et al. Williams-Beuren syndrome: An update and review for the primary physician. Clinical Pediatrics. 1999; 38(4):189-208. cited by applicant . Layer et al. Pancreatic enzyme replacement therapy. Current Gastroenterology Reports. 2001; 3:101-108. cited by applicant . Lebenthal, et al. Enzyme therapy for pancreatic insufficiency: present status and future needs. Pancreas. Jan. 1994;9(1):1-12. cited by applicant . Leeds, et al. Is exocrine pancreatic insufficiency in adult coeliac disease a cause of persisting symptoms? Aliment Pharmacol Ther. Feb. 1, 2007;25(3):265-71. cited by applicant . Levy, et al. Relationship of dietary intake to gastrointestinal symptoms in children with autistic spectrum disorders. Biol Psychiatry. Feb. 15, 2007;61(4):492-7. cited by applicant . Leyfer, et al. Comorbid psychiatric disorders in children with autism: interview development and rates of disorders. J Autism Dev Disord. Oct. 2006;36(7):849-61. cited by applicant . Lieberman. Pharmaceutical Dosage Forms. vol. 2: Disperse Systems. New York Marcel Dekker, Inc. 1996; 243-258. cited by applicant . Life Plus Somazyne accessed Jun. 10, 2016, Online at www.lifeplus.com/media/pdf/piSheets/US/6141-PI_EN.pdf. cited by applicant . Lipase 30, Technical Data sheet, 1 page, Scientific Protein Laboratories LLC Jun. 13, 2005. cited by applicant . Liyanage, et al. Bioavailability of iron from micro-encapsulated iron sprinkle supplement. Food and Nutrition bulletin. 2002; 23(3):133-137. cited by applicant . Lloyd. Lysosome membrane permeability: implications for drug delivery. Adv Drug Deliv Rev. Mar. 30, 2000;41(2):189-200. cited by applicant . Loh, et al. Highly tolerated amino acid substitutions increase the fidelity of Escherichia coli DNA polymerase I. J Biol Chem. Apr. 20, 2007;282(16):12201-9. cited by applicant . Lord, et al. Diagnostic Instruments in Autistic Spectrum Disorders. info.med.yale.edu. 2005; 11:730-771. cited by applicant . Luedtke, et al. Cathepsin A is expressed in a cell- and region-specific manner in the testis and epididymis and is not regulated by testicular or pituitary factors. J Histochem Cytochem. Aug. 2000;48(8):1131-46. cited by applicant . MacDonald. Thyrotoxicosis treated with pancreatic extract and iodine. Lancet. 1943; 244(6251):788. cited by applicant . MacFabe, et al. Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behav Brain Res. 2006;176(1):149-69. cited by applicant . MacReady. Parkinson's Diseasne Treatment: what you should know. Retrieved from the internet on Sep. 15, 2009, http://www.everydayhealth.com/parkinsons-disease-treatment-overview.aspx. cited by applicant . Mannino, et al. Surveillance for asthma--United States, 1960-1995. MMWR CDC Surveill Summ. Apr. 24, 1998;47(1):1-27. cited by applicant . Marcus, et al. A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. J Am Acad Child Adolesc Psychiatry. Nov. 2009;48(11):1110-19. cited by applicant . Marczewska et al. Protein intake in parkinsonian using the EPIC food frequency questionnaire. Mov Diord. Aug. 2006; 21(8):1229-1231. cited by applicant . Marlicz et al. Determination of chymotrypsin in the stool in the diagnosis of chronic pancreatitis. Wiadomosci lekarskie. 1988; 41(11):704-707. (in Polish with English abstract/summary). cited by applicant . Marsh. Neuropsychiatric aspects of parkinson's disease. Psychosomatics. 2000; 41(1):15-23. cited by applicant . Martin, et al. A rapid and sensitive spectrophotometric method for the assay of chymotrypsin. Biol Chem. Feb. 1959;234(2):294-8. cited by applicant . Matikainen, et al. Autonomic dysfunction in long-standing alcoholism. Alcohol Alcohol. 1986;21(1):69-73. Abstract only. cited by applicant . Maurin, et al. Cellular adaptation to amino acid availability: mechanisms involved in the regulation of gene expression. 2006; 319-326. cited by applicant . Mayo Clinic Staff. Autism. Retrieved from internet Mar. 10, 2008, http://www.mayoclinic.com/health/autism/DS00348DSECTION=2. cited by applicant . Mayo Clinic Staff. Bipolar disorder. Jan. 4, 2008, http://www.mayoclinic.com/health/bipolardisorder/DS00356/DSECTION=symptom- s. cited by applicant . Mayo Clinic Staff. Obsessive-compulsive disorder. Dec. 21, 2006. http://www.preferredalternatives.org/lat/WellnessLibrary/anxiety&PanicDis- orders/Obsessive-CompulsiveDisorder/Obsessive-CompulsiveDisorder-Mayoclini- c.pdf. cited by applicant . Mayo Clinic Staff. Oppositional defiant disorder. Dec. 19, 2007, http://www.mayoclinic.com/health/oppositional-defiant-disorder/DS00630/DS- ECTION=symptoms. cited by applicant . McAlonan, et al. Brain anatomy and sensorimotor gating in Asperger's syndrome. ain. Jul. 2002;125(Pt 7):1594-606. cited by applicant . McCormack, et al. Localization of the disulfide bond involved in post-translational processing of glycosylasparaginase and disrupted by a mutation in the Finnish-type aspartylglycosaminuria. J Biol Chem. Feb. 17, 1995;270(7):3212-5. cited by applicant . McCracken, et al. Risperidone in children with autism and serious behavioral problems. N Engl J Med. Aug. 1, 2002;347(5):314-21. cited by applicant . Medsafe. Data sheet for alpha-lactose, Jul. 21, 2008, http://www.medsafe.govt.nz/Profs/Datasheet/a/Alphalactulosesyrup.htm. cited by applicant . Medscape. Burden of Hypertension in the United States Greater Than Ever. www.medscape.com. Jul. 14, 2004. cited by applicant . Merck. Autism, Merck manual online medical library home addition, retrieved from the internet Mar. 10, 2008, http://www.mercl.com/mmhge/sec23/ch286/ch286b.html. cited by applicant . Merriam-Webster 2014 Definition: Precipitate accessed from www.mirriam-webster.com on Sep. 22, 2014. cited by applicant . MeSH browser. Child Development Disorders, Pervasive, and Attention Deficit and Disruptive Behavior Disorders, National Library of medicine. 2001, http://www.nlm.nih.gov/mesh/2002/Mbrowser.html. cited by applicant . Meyer-Lindenberg, et al. Neural mechanisms in Williams syndrome: a unique window to genetic influences on cognition and behavior. Nat. Rev. Neurosci. 2006; 7(5):380-93. cited by applicant . Michael's Naturopathic Programs, Digestive Enzymes, Product #011161, Accessed on Jun. 10, 2016, online at: www.michaelshealth.com/retail/digestive-enzymes-659.html. cited by applicant . Michell et al. Biomarkers and parkinson's disease. Brain. 2004; 127(8):1693-1705. cited by applicant . Millipore EMD catalog (online). Papain, unit definition, EMD Millipore Corp, 2013. Downloaded May 13, 2013. cited by applicant . Minamino, et al. Vascular cell senescence: contribution to atherosclerosis. Circ Res. Jan. 5, 2007;100(1):15-26. cited by applicant . Ming, et al. Autism spectrum disorders: concurrent clinical disorders. J Child Neurol. Jan. 2008;23(1):6-13. cited by applicant . Mitchell, et al. Comparative trial of viokase, pancreatin and Pancrease pancrelipase (enteric coated beads) in the treatment of malabsorption in cystic fibrosis. Aust Paediatr J. Jun. 1982;18(2):114-7. cited by applicant . Mitsui, et al. Role of aminopepridases in the blood pressure regulation. Biological and Pharmaceutical Bulletin of Japan, Pharmaceutical Sociey of Japan. 2004; 27(6):768-771. cited by applicant . Mononen, et al. Aspartylglycosaminuria in the Finnish population: identification of two point mutations in the heavy chain of glycoasparaginase. Proc Natl Acad Sci U S A. Apr. 1, 1991;88(7):2941-5. cited by applicant . Moretti, et al. Acute pancreatitis: hypertonic saline increases heat shock proteins 70 and 90 and reduces neutrophil infiltration in lung injury. Pancreas. Jul. 2009;38(5):507-14. Abstract only. cited by applicant . Munasinghe et al. Digestive enzyme supplementation for autism spectrum disorders: a double-blind randomized controlled trial. J Autism Dev Disord. Sep. 2010;40(9):1131-8. cited by applicant . Munasinghe et al. Digestive enzyme supplementation for autism spectrum disorders: a double-blind randomized controlled trial. J Autism Dev Disord. Sep. 2010;40(9):1131-8. Abstract only. cited by applicant . Nachaegari et al. Coprocessed excipients for solid dosage forms. Pharmaceutical Technology. 2004; p. 52, 54, 56 ,58, 60, 64. cited by applicant . Nagamoto. Jacobson: Psychiatric Secrets, 2nd ed. 2001. Ch 28 Antipsychotic meds. cited by applicant . Neuer, et al. The role of heat shock proteins in reproduction. Hum Reprod Update. Mar.-Apr. 2000;6(2):149-59. cited by applicant . Nevo et al. Acute immune polyneuropathies: correlations of serum antibodies to campylobacter jejuni and helicobacter pylori with anti-gm antibodies and clinical patterns of disease. J of Inf diseases. 1997; 175(S2):S154-6. cited by applicant . Newhorizons. ADD/ADHD: New Perspectives on Attentional Priority Disorders. New Horizons for Learning. Jul. 15, 2008. cited by applicant . NIH, Celiac Disease, National Digestive Diseases Information Clearinghouse: Bethesda, MD, 2008; 12 pages. cited by applicant . NIH. National Institutes of Health. National Diabetes Statistics 2007. diabetes.niddk.nih.gov. Jun. 1, 2008. cited by applicant . NINDS Dysautonimia Information Page, retrieved from the internet Sep. 10, 2009, http://www.ninds.nih.gov/disorders/dysautonomia/dysautonomia.htm. cited by applicant . NINDS Guillain-Barre Syndrome Information Page, retrieved from the internet Sep. 15, 2009, http://www.ninds.nih.gov/disorders/gbs/gbs.htm. cited by applicant . Notice Non-Compliant Amendment dated Jun. 19, 2009 for U.S. Appl. No. 11/232,180. cited by applicant . Notice Non-responsive Amendment dated Sep. 22, 2008 for U.S. Appl. No. 11/232,180. cited by applicant . Notice of allowance dated Jan. 2, 2014 for U.S. Appl. No. 13/204,881. cited by applicant . Notice of allowance dated Feb. 2, 2015 for U.S. Appl. No. 13/926,822. cited by applicant . Notice of Allowance dated Feb. 17, 2012 for U.S. Appl. No. 10/681,018. cited by applicant . Notice of allowance dated Feb. 20, 2015 for U.S. Appl. No. 12/386,051. cited by applicant . Notice of allowance dated Feb. 27, 2015 for U.S. Appl. No. 14/037,696. cited by applicant . Notice of allowance dated Mar. 1, 2016 for U.S. Appl. No. 14/087,930. cited by applicant . Notice of Allowance dated Mar. 21, 2012 for U.S. Appl. No. 12/487,864. cited by applicant . Notice of allowance dated Apr. 3, 2015 for U.S. Appl. No. 13/737,225. cited by applicant . Notice of allowance dated Apr. 10, 2015 for U.S. Appl. No. 13/144,290. cited by applicant . Notice of allowance dated Apr. 14, 2015 for U.S. Appl. No. 13/144,286. cited by applicant . Notice of Allowance dated Apr. 15, 2011 for U.S. Appl. No. 12/487,868. cited by applicant . Notice of allowance dated Apr. 22, 2016 for U.S. Appl. No. 14/528,715. cited by applicant . Notice of Allowance dated Apr. 29, 2011 for U.S. Appl. No. 12/046,402. cited by applicant . Notice of Allowance dated May 23, 2011 for U.S. Appl. No. 09/990,909. cited by applicant . Notice of Allowance dated May 29, 2013 for U.S. Appl. No. 13/481,087. cited by applicant . Notice of allowance dated Jun. 12, 2014 for U.S. Appl. No. 13/448,061. cited by applicant . Notice of Allowance dated Jun. 27, 2011 for U.S. Appl. No. 12/238,415. cited by applicant . Notice of Allowance dated Jun. 28, 2011 for U.S. Appl. No. 12/487,868. cited by applicant . Notice of Allowance dated Jun. 30, 2011 for U.S. Appl. No. 09/990,909. cited by applicant . Notice of allowance dated Jul. 3, 2012 for U.S. Appl. No. 13/271,783. cited by applicant . Notice of Allowance dated Jul. 8, 2011 for U.S. Appl. No. 12/046,402. cited by applicant . Notice of Allowance dated Aug. 8, 2011 for U.S. Appl. No. 12/426,794. cited by applicant . Notice of allowance dated Aug. 11, 2014 for U.S. Appl. No. 13/193,346. cited by applicant . Notice of allowance dated Aug. 19, 2013 for U.S. Appl. No. 13/208,963. cited by applicant . Notice of allowance dated Aug. 30, 2013 for U.S. Appl. No. 12/047,818. cited by applicant . Notice of allowance dated Sep. 9, 2015 for U.S. Appl. No. 13/193,346. cited by applicant . Notice of allowance dated Sep. 15, 2014 for U.S. Appl. No. 14/037,652. cited by applicant . Notice of Allowance dated Sep. 20, 2011 for U.S. Appl. No. 12/283,090. cited by applicant . Notice of allowance dated Oct. 29, 2013 for U.S. Appl. No. 13/204,881. cited by applicant . Notice of allowance dated Nov. 16, 2015 for U.S. Appl. No. 14/493,734. cited by applicant . Notice of allowance dated Dec. 23, 2014 for U.S. Appl. No. 14/007,793. cited by applicant . Notice of allowance dated Dec. 23, 2015 for U.S. Appl. No. 12/493,122. cited by applicant . Notice of Non-Complaint Amendment dated Jun. 2, 2008 for U.S. Appl. No. 12/046,252. cited by applicant . Notice of Non-Compliant Amendment dated Apr. 27, 2010 for U.S. Appl. No. 12/283,090. cited by applicant . Notice of Non-Compliant Amendment dated May 7, 2007 for U.S. Appl. No. 11/213,255. cited by applicant . Notice of Non-Responsive Amendment dated Feb. 11, 2008 for U.S. Appl. No. 11/555,697. cited by applicant . Notice of Non-Responsive Amendment dated Sep. 25, 2008 for U.S. Appl. No. 11/555,697. cited by applicant . O'Connell. Hypertension Guide. cmbi.bjmu.edu. Jul. 14, 2008. cited by applicant . Office action dated Jan. 12, 2012 for U.S. Appl. No. 12/047,818. cited by applicant . Office action dated Jan. 15, 2014 for U.S. Appl. No. 13/836,135. cited by applicant . Office action dated Jan. 15, 2016 for U.S. Appl. No. 13/502,989. cited by applicant . Office action dated Jan. 16, 2014 for U.S. Appl. No. 12/046,252. cited by applicant . Office action dated Jan. 16, 2015 for U.S. Appl. No. 12/535,676. cited by applicant . Office action dated Jan. 22, 2013 for U.S. Appl. No. 13/562,999. cited by applicant . Office action dated Jan. 24, 2014 for U.S. Appl. No. 12/054,343. cited by applicant . Office action dated Jan. 24, 2014 for U.S. Appl. No. 12/786,739. cited by applicant . Office action dated Jan. 25, 2013 for U.S. Appl. No. 13/208,963. cited by applicant . Office action dated Jan. 26, 2016 for U.S. Appl. No. 12/054,343. cited by applicant . Office action dated Jan. 29, 2016 for U.S. Appl. No. 12/786,739. cited by applicant . Office Action dated Feb. 1, 2012 for U.S. Appl. No. 12/493,122. cited by applicant . Office action dated Feb. 1, 2016 for U.S. Appl. No. 13/503,844. cited by applicant . Office action dated Feb. 14, 2013 for U.S. Appl. No. 13/193,346. cited by applicant . Office action dated Feb. 14, 2013 for U.S. Appl. No. 13/407,408. cited by applicant . Office action dated Feb. 17, 2016 for U.S. Appl. No. 14/713,178. cited by applicant . Office action dated Feb. 21, 2013 for U.S. Appl. No. 12/047,818. cited by applicant . Office action dated Feb. 26, 2016 for U.S. Appl. No. 12/535,676. cited by applicant . Office action dated Mar. 2, 2016 for U.S. Appl. No. 14/693,711. cited by applicant . Office Action dated Mar. 5, 2012 for U.S. Appl. No. 12/535,676. cited by applicant . Office action dated Mar. 5, 2013 for U.S. Appl. No. 12/493,122. cited by applicant . Office action dated Mar. 6, 2015 for U.S. Appl. No. 13/757,412. cited by applicant . Office action dated Mar. 11, 2014 for U.S. Appl. No. 11/533,818. cited by applicant . Office Action dated Mar. 19, 2012 for U.S. Appl. No. 13/204,881. cited by applicant . Office action dated Mar. 22, 2016 for U.S. Appl. No. 13/733,873. cited by applicant . Office Action dated Mar. 23, 2012 for U.S. Appl. No. 13/271,783. cited by applicant . Office Action dated Mar. 29, 2011 for U.S. Appl. No. 12/054,343. cited by applicant . Office Action dated Mar. 30, 2011 for U.S. Appl. No. 12/786,739. cited by applicant . Office action dated Mar. 30, 2016 for U.S. Appl. No. 14/296,091. cited by applicant . Office action dated Apr. 4, 2016 for U.S. Appl. No. 13/313,629. cited by applicant . Office Action dated Apr. 5, 2012 for U.S. Appl. No. 11/555,697. cited by applicant . Office action dated Apr. 5, 2016 for U.S. Appl. No. 14/713,242. cited by applicant . Office action dated Apr. 6, 2015 for U.S. Appl. No. 14/493,734. cited by applicant . Office action dated Apr. 6, 2016 for U.S. Appl. No. 13/313,708. cited by applicant . Office Action dated Apr. 9, 2012 for U.S. Appl. No. 13/208,963. cited by applicant . Office action dated Apr. 10, 2014 for U.S. Appl. No. 13/502,989. cited by applicant . Office action dated Apr. 13, 2016 for U.S. Appl. No. 14/612,604. cited by applicant . Office action dated Apr. 16, 2014 for U.S. Appl. No. 13/705,763. cited by applicant . Office action dated Apr. 21, 2015 for U.S. Appl. No. 13/660,642. cited by applicant . Office action dated Apr. 21, 2015 for U.S. Appl. No. 14/087,930. cited by applicant . Office action dated Apr. 22, 2015 for U.S. Appl. No. 13/836,135. cited by applicant . Office action dated Apr. 24, 2015 for U.S. Appl. No. 12/786,739. cited by applicant . Office Action dated Apr. 27, 2011 for U.S. Appl. No. 10/681,018. cited by applicant . Office action dated Apr. 27, 2015 for U.S. Appl. No. 12/054,343. cited by applicant . Office Action dated Apr. 28, 2011 for U.S. Appl. No. 12/283,090. cited by applicant . Office action dated May 6, 2015 for U.S. Appl. No. 12/493,122. cited by applicant . Office action dated May 7, 2015 for U.S. Appl. No. 13/705,763. cited by applicant . Office action dated May 9, 2013 for U.S. Appl. No. 13/204,881. cited by applicant . Office action dated May 12, 2014 for U.S. Appl. No. 13/733,873. cited by applicant . Office action dated May 13, 2014 for U.S. Appl. No. 13/313,629. cited by applicant . Office action dated May 15, 2013 for U.S. Appl. No. 13/502,989. cited by applicant . Office action dated May 15, 2014 for U.S. Appl. No. 13/448,061. cited by applicant . Office action dated May 16, 2014 for U.S. Appl. No. 13/313,708. cited by applicant . Office Action dated May 24, 2011 for U.S. Appl. No. 12/487,864. cited by applicant . Office action dated May 27, 2015 for U.S. Appl. No. 13/502,989. cited by applicant . Office action dated Jun. 3, 2015 for U.S. Appl. No. 13/002,136. cited by applicant . Office action dated Jun. 13, 2012 for U.S. Appl. No. 12/493,122. cited by applicant . Office action dated Jun. 17, 2014 for U.S. Appl. No. 13/737,225. cited by applicant . Office action dated Jun. 17, 2014 for U.S. Appl. No. 13/757,412. cited by applicant . Office action dated Jun. 19, 2014 for U.S. Appl. No. 12/386,051. cited by applicant . Office action dated Jun. 25, 2013 for U.S. Appl. No. 13/144,286. cited by applicant . Office action dated Jun. 25, 2013 for U.S. Appl. No. 13/144,290. cited by applicant . Office action dated Jun. 27, 2012 for U.S. Appl. No. 12/493,147. cited by applicant . Office action dated Jun. 27, 2014 for U.S. Appl. No. 14/007,793. cited by applicant . Office action dated Jun. 29, 2011 for U.S. Appl. No. 11/555,697. cited by applicant . Office action dated Jul. 7, 2014 for U.S. Appl. No. 12/535,676. cited by applicant . Office action dated Jul. 11, 2012 for U.S. Appl. No. 12/573,353. cited by applicant . Office action dated Jul. 15, 2013 for U.S. Appl. No. 13/002,136. cited by applicant . Office action dated Jul. 17, 2015 for U.S. Appl. No. 13/733,873. cited by applicant . Office action dated Jul. 18, 2012 for U.S. Appl. No. 12/047,818. cited by applicant . Office action dated Jul. 31, 2013 for U.S. Appl. No. 13/757,412. cited by applicant . Office action dated Aug. 2, 2013 for U.S. Appl. No. 12/535,676. cited by applicant . Office action dated Aug. 7, 2014 for U.S. Appl. No. 13/836,135. cited by applicant . Office action dated Aug. 13, 2012 for U.S. Appl. No. 13/208,963. cited by applicant . Office action dated Aug. 14, 2013 for U.S. Appl. No. 13/448,061. cited by applicant . Office action dated Aug. 28, 2013 for U.S. Appl. No. 13/313,629. cited by applicant . Office action dated Aug. 29, 2014 for U.S. Appl. No. 13/144,286. cited by applicant . Office action dated Aug. 31, 2015 for U.S. Appl. No. 12/535,676. cited by applicant . Office action dated Sep. 8, 2015 for U.S. Appl. No. 11/533,818. cited by applicant . Office action dated Sep. 9, 2013 for U.S. Appl. No. 13/502,989. cited by applicant . Office action dated Sep. 10, 2015 for U.S. Appl. No. 13/313,629. cited by applicant . Office action dated Sep. 11, 2015 for U.S. Appl. No. 13/313,708. cited by applicant . Office action dated Sep. 13, 2012 for U.S. Appl. No. 13/481,087. cited by applicant . Office action dated Sep. 18, 2014 for U.S. Appl. No. 13/502,989. cited by applicant . Office action dated Sep. 19, 2014 for U.S. Appl. No. 11/533,818. cited by applicant . Office action dated Sep. 19, 2014 for U.S. Appl. No. 13/737,225. cited by applicant . Office action dated Sep. 30, 2014 for U.S. Appl. No. 13/144,290. cited by applicant . Office action dated Sep. 30, 2014 for U.S. Appl. No. 13/660,642. cited by applicant . Office action dated Oct. 2, 2014 for U.S. Appl. No. 12/054,343. cited by applicant . Office action dated Oct. 6, 2014 for U.S. Appl. No. 12/493,122. cited by applicant . Office action dated Oct. 9, 2014 for U.S. Appl. No. 12/786,739. cited by applicant . Office Action dated Oct. 1, 2001 for U.S. Appl. No. 09/466,559. cited by applicant . Office action dated Oct. 10, 2012 for U.S. Appl. No. 13/204,881. cited by applicant . Office action dated Oct. 19, 2011 for U.S. Appl. No. 12/386,051. cited by applicant . Office action dated Oct. 24, 2013 for U.S. Appl. No. 13/313,708. cited by applicant . Office action dated Oct. 25, 2012 for U.S. Appl. No. 13/144,286. cited by applicant . Office action dated Oct. 25, 2012 for U.S. Appl. No. 13/144,290. cited by applicant . Office action dated Oct. 30, 2015 for U.S. Appl. No. 14/528,715. cited by applicant . Office Action dated Oct. 5, 2010 for U.S. Appl. No. 12/046,402. cited by applicant . Office action dated Nov. 7, 2014 for U.S. Appl. No. 13/705,763. cited by applicant . Office Action dated Nov. 14, 2007 for U.S. Appl. No. 11/213,255. cited by applicant . Office Action dated Nov. 15, 2010 for U.S. Appl. No. 12/238,415. cited by applicant . Office action dated Nov. 16, 2015 for U.S. Appl. No. 13/705,763. cited by applicant . Office action dated Nov. 19, 2015 for U.S. Appl. No. 14/713,242. cited by applicant . Office action dated Nov. 20, 2015 for U.S. Appl. No. 14/296,091. cited by applicant . Office action dated Nov. 20, 2015 for U.S. Appl. No. 14/612,604. cited by applicant . Office action dated Nov. 21, 2014 for U.S. Appl. No. 13/926,822. cited by applicant . Office Action dated Nov. 25, 2009 for U.S. Appl. No. 11/232,180. cited by applicant . Office Action dated Nov. 26, 2001 for U.S. Appl. No. 09/466,559. cited by applicant . Office action dated Nov. 29, 2013 for U.S. Appl. No. 13/193,346. cited by applicant . Office action dated Dec. 6, 2012 for U.S. Appl. No. 13/002,136. cited by applicant . Office action dated Dec. 10, 2013 for U.S. Appl. No. 13/407,408. cited by applicant . Office action dated Dec. 10, 2015 for U.S. Appl. No. 13/836,135. cited by applicant . Office Action dated Jan. 21, 2011 for U.S. Appl. No. 12/386,051. cited by applicant . Office action dated Dec. 12, 2013 for U.S. Appl. No. 13/144,286. cited by applicant . Office action dated Dec. 13, 2013 for U.S. Appl. No. 12/493,122. cited by applicant . Office action dated Dec. 13, 2013 for U.S. Appl. No. 13/144,290. cited by applicant . Office action dated Dec. 15, 2011 for U.S. Appl. No. 12/493,147. cited by applicant . Office action dated Dec. 15, 2015 for U.S. Appl. No. 14/087,930. cited by applicant . Office action dated Dec. 16, 2013 for U.S. Appl. No. 12/535,676. cited by applicant . Office action dated Dec. 18, 2014 for U.S. Appl. No. 14/037,696. cited by applicant . Office action dated Dec. 18, 2015 for U.S. Appl. No. 14/640,385. cited by applicant . Office Action dated Dec. 19, 2005 for U.S. Appl. No. 10/730,567. cited by applicant . Office action dated Dec. 19, 2014 for U.S. Appl. No. 13/733,873. cited by applicant . Office Action dated Dec. 22, 2006 for U.S. Appl. No. 10/681,018. cited by applicant . Office action dated Dec. 24, 2015 for U.S. Appl. No. 13/757,412. cited by applicant . Office Action dated Jan. 29, 2002 for U.S. Appl. No. 09/707,395. cited by applicant . Office Action dated Jan. 8, 2010 for U.S. Appl. No. 10/681,018. cited by applicant . Office Action dated Mar. 18, 2008 for U.S. Appl. No. 11/468,379. cited by applicant . Office Action dated Mar. 25, 2008 for U.S. Appl. No. 11/213,382. cited by applicant . Office Action dated Mar. 28, 2008 for U.S. Appl. No. 11/555,697. cited by applicant . Office Action dated Apr. 12, 2010 for U.S. Appl. No. 09/990,909. cited by applicant . Office Action dated Apr. 21, 2008 for U.S. Appl. No. 11/232,180. cited by applicant . Office Action dated Apr. 22, 2003 for U.S. Appl. No. 09/929,592. cited by applicant . Office Action dated May 22, 2002 for U.S. Appl. No. 09/466,559. cited by applicant . Office Action dated Jun. 30 2004 for U.S. Appl. No. 10/730,567. cited by applicant . Office Action dated Jul. 22, 2010 for U.S. Appl. No. 12/049,613. cited by applicant . Office Action dated Jul. 29, 2003 for U.S. Appl. No. 09/990,909. cited by applicant . Office Action dated Jul. 30, 2002 for U.S. Appl. No. 09/707,395. cited by applicant . Office Action dated Jul. 30, 2002 for U.S. Appl. No. 09/990,909. cited by applicant . Office Action dated Jul. 6, 2010 for U.S. Appl. No. 11/533,818. cited by applicant . Office Action dated Aug. 13, 2002 for U.S. Appl. No. 09/929,592. cited by applicant . Office Action dated Aug. 18, 2008 for U.S. Appl. No. 10/681,018. cited by applicant . Office Action dated Aug. 18, 2010 for U.S. Appl. No. 10/681,018. cited by applicant . Office Action dated Aug. 20, 2010 for U.S. Appl. No. 12/283,090. cited by applicant . Office Action dated Aug. 25, 2010 for U.S. Appl. No. 12/487,868. cited by applicant . Office Action dated Aug. 26, 2003 for U.S. Appl. No. 10/041,073. cited by applicant . Office Action dated Aug. 3, 2009 for U.S. Appl. No. 11/555,697. cited by applicant . Office Action dated Aug. 7, 2007 for U.S. Appl. No. 10/681,018. cited by applicant . Office Action dated Aug. 8, 2007 for U.S. Appl. No. 11/213,382. cited by applicant . Office Action dated Sep. 22, 2004 for U.S. Appl. No. 10/730,567. cited by applicant . Office Action dated Sep. 24, 2009 for U.S. Appl. No. 12/046,252. cited by applicant . Office Action dated May 11, 2016 U.S. Appl. No. 14/713,242. cited by applicant . Okahata, et al. Lipid-coated enzymes as efficient catalysts in organic media. Trends in Biotechnology. 1997; 15(2):50-54. cited by applicant . Olivar-Parra, et al. Training referential communicative skills to individuals with autism spectrum disorder: a pilot study. Psychological Reports. 2011; 109:921-939. cited by applicant . Owley, et al. Multisite, double-blind, placebo-controlled trial of porcine secretin in autism. J Am Acad Child Adolesc Psychiatry. Nov. 2001;40(11):1293-9. cited by applicant . Pancrease. Patient information leaflet. Pancrease HL Capsules. Last updated Apr. 30, 2013. Janssen-cilag LTD. www.medicines.org.uk/EMC/medicine/7326. cited by applicant . Pancreatic Enzyme Concentrate (PEC) Undiluted, Technical Data Sheet. 1 page, Scientific Protein Laboratories LLC Jun. 13, 2005. cited by applicant . Pancreatin 4X USP, Technical Data Sheet, 1 page, Scientific Protein laboratories LLC Jun. 13, 2005. cited by applicant . Pancreatin 8X USP Powder. Product Specification. Jul. 2000. In: Product Manual. American Laboratories Incorporated. Omaha, NE. p. 1. cited by applicant . Parisi et al. Evaluation of new rapid commercial enzyme immunoassay for detection of crytosporidium oocysts in untreated stool specimens. J Clin Microbiol. 1995; 33(7):1963-1965. cited by applicant . Park, et al. Increased apoptosis in cystinotic fibroblasts and renal proximal tubule epithelial cells results from cysteinylation of protein kinase Cdelta. J Am Soc Nephrol. Nov. 2006;17(11):3167-75. cited by applicant . Parkinsons Disease Foundation. Parkinson's Disease Q&A. 2007. 1-44. cited by applicant . Parkinsons Disease Foundation. Ten Frequently-Asked Questions about Parkinson's Disease. 2006. cited by applicant . Parracho, et al. Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol. Oct. 2005;54(Pt 10):987-91. cited by applicant . Patel, et al. Formulation and evaluation of mucoadhesive glipizide microspheres. AAPS PharmSciTech. 2005; 6(1):E49-E55. cited by applicant . Pdtalks. Motivational & Inspirational Speaking From a Parkinson's Patient Perspective. pdtalks.com/Parkinson_s_Disease.html. Jul. 14, 2008. cited by applicant . Perman et al. Role of ph in production of hydrogen from carbohydrates by colonic bacterial flora. J Clin Invest. 1981; 24(4):684-685. cited by applicant . Persico, et al. Searching for ways out of the autism maze: genetic, epigenetic and environmental clues. Trends Neurosci. Jul. 2006;29(7):349-58. cited by applicant . Peters et al. Prevalence of enteric parasites in homosexual patients attending an outpatient clinic. J of Clin Micro. 1986; 24(4):684-685. cited by applicant . Peters, et al. Treatment of alcoholic polyneuropathy with vitamin B complex: a randomised controlled trial. Alcohol Alcohol. Nov.-Dec. 2006;41(6):636-42. Epub Aug. 21, 2006. cited by applicant . Petrolatum: Pharmaceutical Excipients. London: Pharmaceutical Press. 2006. 1-6. cited by applicant . Polanczyk, et al. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. Jun. 2007;164(6):942-8. cited by applicant . Ponsky, et al. Alterations in gastrointestinal physiology after Roux-en-Y gastric bypass. J Am Coll Surg. Jul. 2005;201(1):125-31. cited by applicant . Preliminary Amendment dated May 18, 2009 for U.S. Appl. No. 12/046,252. cited by applicant . Puri, et al. Isolated segmental duodenal ganglionosis. Indian Journal of Radiology and Imaging. 2000; 153-154. cited by applicant . Raimondo, et al. Rapid endoscopic secretin simulation test and discrimination of chronic pancreatisis and pancreatic cancer from disease controls. Clin Gastroenterol Hepatol. Sep. 2003;1(5):397-403. cited by applicant . Rajakumar, et al. Proteasomal activity in placentas from women with preeclampsia and intrauterine growth restriction: implications for expression of HIF-alpha proteins. Placenta. Mar. 2008;29(3):290-9. Epub Jan. 28, 2008. cited by applicant . Rakonczay, et al. A new severe acute necrotizing pancreatitis model induced by L-ornithine in rats. Crit Care Med. Jul. 2008;36(7):2117-27. cited by applicant . Ray, et al. Growth factor regulation of enterocyte nutrient transport during intestinal adaptation. Am J Surg. Apr. 2002;183(4):361-71. cited by applicant . Reeves, G. et al. Pharmacological Management of Attention-deficit hyperactivity disorder, Expert Opinion on Pharmacotherapy, 5:6; 1313-1320. (Feb. 25, 2005)DOI: 10.1517/14656566.5.6.1313 http://dx.doi.org/10.1517/14656566.5.6.1313. cited by applicant . Regan, et al. Comparative effects of antacids, cimetidine and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency. N Engl J Med. Oct. 20, 1977;297(16):854-8. cited by applicant . Remtulla et al. Stool chymotrypsin activity measured by a spectrophotometric procedure to identify pancreat disease in infants. Clinical Biochemistry. Dec. 1986; 19:341-342. cited by applicant . Response dated Oct. 3, 2006 to Restriction Requirement dated Sep. 12, 2006 for U.S. Appl. No. 10/681,018. cited by applicant . Response dated Apr. 29, 2010 to Notice of Non-Compliant Amendment dated Apr. 27, 2010 for U.S. Appl. No. 12/283,090. cited by applicant . Response dated Jun. 17, 2008 to Advisory Action dated Jun. 3, 2008 for U.S. Appl. No. 10/681,018. cited by applicant . Response dated Jun. 24, 2002 to Restriction Requirement dated May 22, 2002 for U.S. Appl. No. 09/990,909. cited by applicant . Response dated Jun. 7, 2007 to Notice of Non-Compliant Amendment dated May 7, 2007 for U.S. Appl. No. 11/213,255. cited by applicant . Restriction Requirement dated Oct. 17, 2007 for U.S. Appl. No. 11/555,697. cited by applicant . Restriction Requirement dated Oct. 7, 2009 for U.S. Appl. No. 12/283,090. cited by applicant . Restriction Requirement dated Jan. 10, 2008 for U.S. Appl. No. 11/232,180. cited by applicant . Restriction Requirement dated Jan. 13, 2010 for U.S. Appl. No. 12/487,868. cited by applicant . Restriction Requirement dated Dec. 10, 2009 for U.S. Appl. No. 11/533,818. cited by applicant . Restriction Requirement dated Apr. 23, 2003 for U.S. Appl. No. 09/990,909. cited by applicant . Restriction Requirement dated May 22, 2002 for U.S. Appl. No. 09/990,909. cited by applicant . Restriction Requirement dated May 9, 2007 for U.S. Appl. No. 11/213,382. cited by applicant . Restriction Requirement dated Jun. 22, 2007 for U.S. Appl. No. 11/213,255. cited by applicant . Restriction Requirement dated Sep. 12, 2006 for U.S. Appl. No. 10/681,018. cited by applicant . Revolution health. Enzyme therapy. revolutionhealth.com/drugs-treatments/enzyme-therapy. Sep. 2, 2008. cited by applicant . Richards, et al. Diagnosis, management, and treatment of Alzheimer disease: a guide for the internist. Arch Intern Med. Apr. 26, 1999;159(8):789-98. cited by applicant . Rider, et al. Perspective of biochemical research in the neuronal ceroid-lipofuscinosis. Am J Med Genet. Feb. 15, 1992;42(4):519-24. cited by applicant . Rogers. No more heartburn: Stop the pain in 30 days--naturally. 2000; 172. cited by applicant . Rottier, et al. Lack of PPCA expression only partially coincides with lysosomal storage in galactosialidosis mice: indirect evidence for spatial requirement of the catalytic rather than the protective function of PPCA. Hum Mol Genet. Oct. 1998;7(11):1787-94. cited by applicant . Roxas, et al. Colds and influenza: a review of diagnosis and conventional, botanical, and nutritional considerations. Alternative Medicine Review. 2007; 12(1):25-48. cited by applicant . Rubenstein, et al. Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav. Oct. 2003;2(5):255-67. cited by applicant . Sahelian. Enzymes. raysahelian.com/enzymes.html. Sep. 2, 2008. cited by applicant . Sandler, et al. Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder. N Engl J Med. Dec. 9, 1999;341(24):1801-6. cited by applicant . Sandler et al. Short term benefit from oral vancomycin treatment of regressive-onset autism. J of Child Neuro. 2000; 15(7):42-435. cited by applicant . Schafer, et al. Stress kinases and heat shock proteins in the pancreas: possible roles in normal function and disease. J Gastroenterol. 2000;35(1):1-9. cited by applicant . Schiller. Review article: the therapy of constipation. Aliment Pharmacol Ther. 2001; 15:749-763. cited by applicant . Schizophreniform disorder. Merck Manuals Online Medical Library. Nov. 2005. (in Japanese with English translation). cited by applicant . Schneider, et al. Oral human immunoglobulin for children with autism and gastrointestinal dysfunction: a prospective, open-label study. J Autism Dev Disord. Nov. 2006;36(8):1053-64. cited by applicant . Schreck et al. Food preferences and factors influecing food selectivity for children with autism spectrum disorders. Res Develop Disabil. 2006; 27:353-363. cited by applicant . Schumann. Medical, nutritional and technological properties of lactulose. An update. Eur J Nutr. Nov. 2002;41 Suppl 1:|17-25. cited by applicant . Seltzer, et al. The Symptoms of Autism Spectrum Disorders in Adolescence and Adulthood. Journal of Autism and Developmental Disorders. 2003; 33(6):565-581. cited by applicant . Seneca et al. Enhancement of brain I-dopa concetration with a-chymotrypsm. J American Geriatrics Society. 1973; 256-258. Abstract only. cited by applicant . Serna, et al. Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections. Curr Opin Gastroenterol. Jan. 2008;24(1):38-47. cited by applicant . Settembre, et al. A block of autophagy in lysosomal storage disorders. Hum Mol Genet. Jan. 1, 2008;17(1):119-29. cited by applicant . Shadel. Expression and maintenance of mitochondrial DNA: new insights into human disease pathology. Am J Pathol. Jun. 2008;172(6):1445-56. cited by applicant . Shaul. Report to the Chairman and Ranking Minority Member, Subcommittee on Human Rights and Wellness, Committee on Government Reform, House of Representatives. GEO. Jan. 2005. 1-40. cited by applicant . Shelby, et al. Enzymatic debridement with activated whole pancreas. American Journal of Surgery. Oct. 1958; 96(4):545-549. cited by applicant . Sherwood et al. A new class of high-functionality excipients: silicified microcrystalline cellulose. Pharm Tech. 1998; 22(10):78-88. cited by applicant . Sherwood, et al. Activation of trypsinogen in large endocytic vacuoles of pancreatic acinar cells. Proc Natl Acad Sci U S A. Mar. 27, 2007;104(13):5674-9. cited by applicant . Shimabukuro, et al. Medical expenditures for children with an autism spectrum disorder in a privately insured population. J Autism Dev Disord. 2007;38(3):546-52. cited by applicant . Shpacovitch, et al. Protease-activated receptors: novel PARtners in innate immunity. Trends Immunol. Dec. 2007;28(12):541-50. cited by applicant . Shpacovitch, et al. Role of protease-activated receptors in inflammatory responses, innate and adaptive immunity. J Leukoc Biol. Jun. 2008;83(6):1309-22. cited by applicant . Sienaert, et al. Evidence-based treatment strategies for treatment-resistant bipolar depression: a systematic review. Bipolar Disord. Feb. 2013;15(1):61-9. doi: 10.1111/bdi.12026. Epub Nov. 27, 2012. cited by applicant . Sillanaukee, et al. Improved diagnostic classification of alcohol abusers by combining carbohydrate-deficient transferrin and gamma-glutamyltransferase. Clin Chem. Apr. 2001;47(4):681-5. cited by applicant . Simonoff, et al. Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. J Am Acad Child Adolesc Psychiatry. Aug. 2008;47(8):921-9. cited by applicant . Singh, et al. Plasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism. J Neuroimmunol. May 1996;66(1-2):143-5. cited by applicant . Skeels et al. Crytosporidium infection in Oregon public health clinic patients 1985-88: the value of statewide laboratory surveillance. AJPH. 1990; 80(3):305-308. cited by applicant . Skinner, et al. Treatment of Prion Disease with Heterologous Prion Proteins. PLoS One. Jul. 2, 2015;10(7):e0131993. doi: 10.1371/journal.pone.0131993. eCollection 2015. cited by applicant . Smith, et al. Fecal chymotrypsin and trypsin determinations. Canadian Medical Association Journal. 1971; 104(8):691-4 and 697. cited by applicant . Statemaster. Number of Children with Autism (most recent) by state. Statemaster.com Jul. 14, 2008. cited by applicant . Statemaster. Number of Children with Autism (most recent w/graph) by state. Statemaster.com Jul. 14, 2003. cited by applicant . Statemaster. Number of Children with Autism (per capita)(most recent) by state. Statemaster.com Jul. 14, 2003. cited by applicant . Stein, et al. Nitrogen metabolism in normal and hyperkinetic boys. Am J Clin Nutr. Apr. 1984;39(4):520-4. cited by applicant . Steinherz, et al. Patterns of amino acid efflux from isolated normal and cystinotic human leucocyte lysosomes. J Biol Chem. Jun. 10, 1982;257(11):6041-9. cited by applicant . Sternby, et al. Carboxyl Ester Lipase (Bile Salt-Stimulated Lipase), Colipase, Lipase, and Phospholipase A2 Levels in Pancreatic Enzyme Supplements, 1997, Scandinavian Journal of Gastroenterology 32(3): 261-267. cited by applicant . Stoll, et al. Enteral nutrient intake level determines intestinal protein synthesis and accretion rates in neonatal pigs. Am J Physiol Gastrointest Liver Physiol. Aug. 2000;279(2):G288-94. cited by applicant . Stott, et al. MMR and Autism in Perspective: the Denmark Story. J. Am Phys Surg. 2004; 9(3):89-91. cited by applicant . Strader, et al. Structural basis of .beta.-adrenergic receptor function. FASEB J. May 1989;3(7):1825-32. cited by applicant . Sturmey. Secretin is an ineffective treatment for pervasive developmental disabilities: a review of 15 double-blind randomized controlled trials. Res Dev Disabil. Jan.-Feb. 2005;26(1):87-97. cited by applicant . Sundstrom, et al. A deadly prion disease: fatal familial insomnia. J Neurosci Nurs. Dec. 2003;35(6):300-5. Abstract only. cited by applicant . Supplemental Amendment and Response dated Jun. 8, 2010 to Restriction Requirement dated Oct. 7, 2009 for U.S. Appl. No. 12/283,090. cited by applicant . Swayne, et al. Pathobiology of H5N2 Mexican avian influenza virus infections of chickens. Vet Pathol. Nov. 1997;34(6):557-67. cited by applicant . Tager-Flusberg, et al. Language disorders: autism and other pervasive developmental disorders. Pediatr Clin North Am. Jun. 2007;54(3):469-81, vi. cited by applicant . Tamaro. Vitamin K deficiency as a cause of autistic symptoms. Http://web.archive.org/web/20090612022246/http://www.gutresearch.com/Vita- minK.pdf. Published Jun. 12, 2009 as per Wayback Engine. cited by applicant . Terrie, et al. Understanding Pancreatic Enzyme Products. Dec. 15, 2008. cited by applicant . The Alzheimer's Association. Basics of Alzheimer's Disease. 2005, 32 pages. http://www.alz.org/national/documents/brochure_Basicsofalz_low/pdf- . cited by applicant . Thefreedictionary. Term Sprinkles. Www.thefreedictionary.com. Accessed Nov. 2, 2011. 1 page. cited by applicant . Thomas, et al. Defective protein folding as a basis of human disease. Trends Biochem Sci. Nov. 1995;20(11):456-9. cited by applicant . Tiedermann, et al. Identification of a potent natural triterpenoid inhibitor of proteosome chymotrypsin-like activity and NF-kappaB with antimyeloma activity in vitro and in vivo. Blood. Apr. 23, 2009;113(17):4027-37. cited by applicant . Torrente, et al. Focal-enhanced gastritis in regressive autism with features distinct from Crohn's and Helicobacter pylori gastritis. Am J Gastroenterol. Apr. 2004;99(4):598-605. cited by applicant . Torrente, et al. Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Mol Psychiatry. 2002;7(4):375-82, 334. cited by applicant . Tran, et al. Treatment of complex regional pain syndrome: a review of the evidence. Can J Anaesth. Feb. 2010;57(2):149-66. cited by applicant . Trauner, et al. Specific cognitive deficits in young children with cystinosis: evidence for an early effect of the cystinosin gene on neural function. J Pediatr. Aug. 2007;151(2):192-6. cited by applicant . Troy. Pancreatic Enzymes. Remington: The Science and Practice of Pharmacy, 21st edition. Lippincot Williams & Wilkins, 2006. p. 1304. cited by applicant . Tsan, et al. Heat shock proteins and immune system. J Leukoc Biol. Jun. 2009;85(6):905-10. cited by applicant . Tsang et al. Extragastroduodenal conditions associated with Heliobacter pylori infection. Hong Kong Medical Journal. 1999; 5(2):169-174. cited by applicant . Uhlmann, et al. Potential viral pathogenic mechanism for new variant inflammatory bowel disease. Mol Pathol. Apr. 2002;55(2):84-90. cited by applicant . UK search and examination report dated Mar. 26, 2013 for GB 1111565.6. cited by applicant . UK search and examination report dated Mar. 27, 2013 for GB 1111566.4. cited by applicant . UK search and examination report dated Apr. 18, 2013 for GB 1117669.0. cited by applicant . Ultresa--FDA Prescribing Information Side Effects and Uses. Revised Sep. 2014. cited by applicant . Unis, et al. A randomized, double-blind, placebo-controlled trial of porcine versus synthetic secretin for reducing symptoms of autism. J Am Acad Child Adolesc Psychiatry. Nov. 2002;41(11):1315-21. cited by applicant . UPI. Number of autistic Calif. students triples. United Press International. Jul. 12, 2008. cited by applicant . U.S. Appl. No. 11/533,818 Final Office Action dated Jun. 7, 2016. cited by applicant . U.S. Appl. No. 12/535,676 Non-Final Office Action dated Apr. 21, 2017. cited by applicant . U.S. Appl. No. 13/002,136 Final Office Action dated Jun. 24, 2016. cited by applicant . U.S. Appl. No. 13/002,136 Non-Final Office Action dated Feb. 27, 2017. cited by applicant . U.S. Appl. No. 13/193,346 Notice of Allowability dated Jun. 2, 2016. cited by applicant . U.S. Appl. No. 13/313,629 Notice of Allowance dated Dec. 22, 2016. cited by applicant . U.S. Appl. No. 13/313,708 Notice of Allowance dated Dec. 15, 2016. cited by applicant . U.S. Appl. No. 13/503,844 Office Action dated Mar. 27, 2017. cited by applicant . U.S. Appl. No. 13/705,763 Final Office Action dated May 24, 2016. cited by applicant . U.S. Appl. No. 13/757,412 Final Office Action dated Jun. 30, 2016. cited by applicant . U.S. Appl. No. 13/757,412 Office Action dated Feb. 10, 2017. cited by applicant . U.S. Appl. No. 13/836,135 Office Action dated Jul. 22, 2016. cited by applicant . U.S. Appl. No. 14/296,091 Final Office Action dated Jan. 3, 2017. cited by applicant . U.S. Appl. No. 14/612,580 Office Action dated Sep. 21, 2016. cited by applicant . U.S. Appl. No. 14/612,604 Notice of Allowance dated Jul. 20, 2016. cited by applicant . U.S. Appl. No. 14/639,425 Notice of Allowance dated Mar. 10, 2017. cited by applicant . U.S. Appl. No. 14/639,425 Office Action dated Jul. 14, 2016. cited by applicant . U.S. Appl. No. 14/640,385 Supplemental Notice of Allowability dated May 26, 2016. cited by applicant . U.S. Appl. No. 14/693,711 Final Office Action dated Dec. 15, 2016. cited by applicant . U.S. Appl. No. 14/693,711 Notice of Allowance dated Apr. 21, 2017. cited by applicant . U.S. Appl. No. 14/713,178 Advisory Office Action dated Jan. 19, 2017. cited by applicant . U.S. Appl. No. 14/713,178 Final Office Action dated Oct. 14, 2016. cited by applicant . U.S. Appl. No. 14/713,178 Notice of Allowance dated Apr. 12, 2017. cited by applicant . U.S. Appl. No. 14/713,221 Final Office Action dated Jun. 16, 2016. cited by applicant . U.S. Appl. No. 14/713,221 Non-Final Office Action dated Dec. 30, 2016. cited by applicant . U.S. Appl. No. 14/713,242 Office Action dated Dec. 7, 2016. cited by applicant . U.S. Appl. No. 14/921,896 Office Action dated Apr. 26, 2017. cited by applicant . U.S. Appl. No. 15/074,115, filed Mar. 18, 2016. cited by applicant . U.S. Appl. No. 15/089,842, filed Apr. 4, 2016. cited by applicant . U.S. Appl. No. 14/639,425, filed Mar. 5, 2015. cited by applicant . U.S. Appl. No. 14/640,385, filed Mar. 6, 2015. cited by applicant . U.S. Appl. No. 14/693,711, filed Apr. 22, 2015. cited by applicant . U.S. Appl. No. 14/713,178, filed May 15, 2015. cited by applicant . U.S. Appl. No. 14/713,221, filed May 15, 2015. cited by applicant . U.S. Appl. No. 14/713,242, filed May 15, 2015. cited by applicant . U.S. Appl. No. 14/612,580 Office Action dated Dec. 24, 2015. cited by applicant . USDA. FDA Drug Safety Communication: Clostridium difficile-associated diarrhea can be associated with stomach acid drugs known as proton pump inhibitors (PPIs). Safety announcement. Feb. 8, 2012. Accessed Apr. 1, 2013. http://www.fda.gov/drugs/drugsafety/ucm290510.htm. cited by applicant . USP (32)-NF(27) 2009, Pancreatin, V.3, pp. 3194-3195. cited by applicant . Valicenti-McDermott, et al. Frequency of gastrointestinal symptoms in children with autistic spectrum disorders and association with family history of autoimmune disease. J Dev Behav Pediatr. Apr. 2006;27(2 Suppl):S128-36. cited by applicant . Vargas, et al. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol. Jan. 2005;57(1):67-81. cited by applicant . Vellard. The enzyme as drug: application of enzymes as pharmaceuticals. Curr Opin Biotechnol. Aug. 2003;14(4):444-50. cited by applicant . Vilanova, et al. Preparative isolation of the two forms of pig pancreatic pro-(carboxypeptidase A) and their monomeric carboxypeptidases A. Biochem J. Aug. 1, 1985;229(3):605-9. cited by applicant . Viokace--FDA Prescribing Information, Side Effects and Uses. Revised Mar. 2012. cited by applicant . Vojdani, et al. Antibodies against CNS antigens in autism: Possible cross-reaction with dietary proteins and infectious agent antigens. Neuropsychiatric Disorders and Infection. 2004; 19:171-186. cited by applicant . Vojdani, et al. Heat shock protein and gliadin peptide promote development of peptidase antibodies in children with autism and patients with autoimmune disease. Clin Diagn Lab Immunol. May 2004;11(3):515-24. cited by applicant . Vojdani, et al. Immune response to dietary proteins, gliadin and cerebellar peptides in children with autism. Nutr Neurosci. Jun. 2004;7(3):151-61. cited by applicant . Volkmar, et al. Practice Parameters for the Assessment and Treatment of Children, Adolescents, and Adults with Autism and other Pervasive Developmental Disorders. American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry. (Part 2) Dec. 1999;38(12):1611-6. cited by applicant . Volkmar, et al. Practice parameters for the assessment and treatment of children, adolescents, and adults with autism and other pervasive developmental disorders. American Academy of Child and Adolescent Psychiatry Working Group on Quality Issues. J Am Acad Child Adolesc Psychiatry. (Part 1) Dec. 1999;38(12 Suppl):32S-54S. cited by applicant . Wakefield. Autistic enterocolitis: is it a histopathological entity? Histopathology. 2006; 1-5. cited by applicant . Wakefield. Enterocolitis, Autism, and Measles Virus. Consensus in Child Neurology: Biological Bases and Climical Perspectives in Autism. 2002; 74-81. cited by applicant . Wakefield, et al. Enterocolitis in children with developmental disorders. Am J Gastroenterol. Sep. 2000;95(9):2285-95. cited by applicant . Wakefield, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. Feb. 28, 1998;351(9103):637-41. cited by applicant . Wakefield, et al. Review article: the concept of entero-colonic encephalopathy, autism and opioid receptor ligands. Aliment Pharmacol Ther. Apr. 2002;16(4):663-74. cited by applicant . Wakefield, et al. The significance of ileo-colonic lymphoid nodular hyperplasia in children with autistic spectrum disorder. Eur J Gastroenterol Hepatol. Aug. 2005;17(8):827-36. cited by applicant . Wakefield. The gut-brain axis in childhood developmental disorders. J Pediatr Gastroenterol Nutr. May-Jun. 2002;34 Suppl 1:S14-7. cited by applicant . Walsh, et al. Heat shock and the role of the HSPs during neural plate induction in early mammalian CNS and brain development. Cell Mol Life Sci. Feb. 1997;53(2):198-211. cited by applicant . Walsh, et al. Reduced violent behavior following chemical therapy. Physiology and behavior. 2004; 82:835-839. cited by applicant . Wang, et al. Activation of Ras/Erk pathway by a novel MET-interacting protein RanBPM. J Biol Chem. Sep. 27, 2002;277(39):36216-22. cited by applicant . We Move, PD Workbook, The Wemove Clinician's Guide to Parkinson's Disease, 2006. cited by applicant . Weintraub, et al. Morphometric studies of pancreatic acinar granule formation in NCTR-Balb/c mice. J Cell Sci. May 1992;102 ( Pt 1):141-7. cited by applicant . Welch, et al. Brain effects of chronic IBD in areas abnormal in autism and treatment by single neuropeptides secretin and oxytocin. J Mol Neurosci. 2004;25(3):259-74. cited by applicant . Wender et al. Prevalence of attention deficit disorder, residual type, and other psychiatric disorders in patients with irritable colon syndrome. Am J Psychiatry. 1983; 140(12):1579-82 Abstract only. cited by applicant . Whitehouse. Fact Sheet: Combating Autism Act of 2006. www.whitehouse.gov. Dec. 19, 2006. cited by applicant . Williams, et al. Eating habits of children with autism. Pediatr Nurs. May-Jun. 2000;26(3):259-64. cited by applicant . Williams, et al. Intravenous secretin for autism spectrum disorders (ASD). Cochrane Database Syst Rev. Apr. 18, 2012;4:CD003495. doi: 10.1002/14651858.CD003495.pub3. cited by applicant . Wisniewski, et al. Therapeutic approaches for prion and Alzheimer's diseases. FEBS J. Aug. 2007;274(15):3784-98. Epub Jul. 6, 2007. cited by applicant . Witmer. ADD and ADHD Statistics--CDC Report Looks at Attention-Deficit/Hyperactivity Disorder. About.com--Parenting of Adolescents. Jul. 15, 2008. cited by applicant . Wohlman et al. Enhancement of drug activity by chymotrypsin, penicillin penetration into granulomatous sesions and inflammatory fluids. Cellular and Molecular Life Sciences. 1969; 25(9):953-954. cited by applicant . Wolfson, D., Making sense of digestive enzymes, Klaire Labs, Mar. 13, 2006. cited by applicant . Woodward et al. Ischaemic enterocolitis complicating aidiopathic dysatuonomia. Gut. 1998;43:285-287. cited by applicant . Xu. Pancreatin therapy in chronic pancreatitis. Clin J Dig, May 2005; 25(5):313-315. (in Chinese with English translation). cited by applicant . Yahoo!.com. Who is affected by Parkinson's disease. Yahoo! Health. Jul. 14, 2008. cited by applicant . Yazbak. Autism in the United States: a perspective. Journal of American Physicians and Surgeons. 2003;8:103-107. cited by applicant . Youngberg, et al. Comparison of gastrointestinal pH in cystic fibrosis and healthy subjects. Dig Dis Sci. May 1987;32(5):472-80. cited by applicant . Yuan, et al.. Freeze-Thaw Stability of Three Waxy Maize Starch Pastes Measured by Centrifugation and Calorimetry. Cereal Chem. 1998; 75(4):571-573. cited by applicant . Zeiner, et al. Mammalian protein RAP46: an interaction partner and modulator of 70 kDa heat shock proteins. EMBO J. Sep. 15, 1997;16(18):5483-90. cited by applicant . Zenpep--FDA Prescribing Information, Side Effects and Uses. Revised Sep. 2014. cited by applicant . Zhang et al. Lactulose-mannitol intestinal permeability test in children with diarrhea caused by rotavirus and cryptosporidium. J of Pediatric Gastro & Nutrition. 2000; 31(1):16-21. cited by applicant . Alexrod FB et al. Hereditary sensory an autonomic neuropathies: types II, III and IV. Orphanet Journal of Rare Diseases, 2:39 (2007). cited by applicant . Anderson, George M., et al. Determination of serotonin in whole blood, platelet-rich plasma, platelet-poor plasma and plasma ultrafiltrate. Life Sciences 40(11):1063-1070 (Mar. 16, 1987) [Abstract Only]. cited by applicant . Arnold, GL et al. Plasma amino acids profiles in children with autism: potential risk of nutritional deficiencies. J. Autism Dev. Disord. 33(4):449-454 (Aug. 2003) [Abstract Only]. cited by applicant . Balasubramanian, Mukundh N. et al. Asparagine synthetase: regulation by cell stress and involvement in tumor biology, Am. J. Physiol. Endocrinol. Metab. 304(8):E789-E799 (Apr. 15, 2013). cited by applicant . Beliaev, O.A. The therapeutic efficacy of the triase preparation in experimental pancreatic exocrine insufficiency. Eksp Lin Farmakiol. 57:38-40 (1994) (Abstract Only--English Translation). cited by applicant . Co-pending U.S. Appl. No. 15/840,883, filed Dec. 13, 2017. cited by applicant . Co-pending U.S. Appl. No. 16/103,192, filed Aug. 14, 2018. cited by applicant . Coutinho, Am et al. Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism. Mol Psychiatry. Mar. 2004;9(3):264-71. cited by applicant . Fafournoux, P. et al. Amino acid regulation of gene expression. Biochemical Journal, 351:1-12(2000). cited by applicant . Girella, E. et al. The assay of chymotrypsin in stool as a simple and effective test of exocrine pancreatic activity in cystic fibrosis. Pancreas, 3(3):254-262 (1988). cited by applicant . Hamel, E. et al. Effects of Cocaine on Rat Pancreatic Enzyme Secretion and Protein Synthesis, Digestive Diseases, 23(3):264-268 (Mar. 1978). cited by applicant . International Application No. PCT/US18/26841 International Search Report and Written Opinion dated Jul. 3, 2018. cited by applicant . Nestler, et al. Delta-FosB: A sustained molecular switch for addiction. PNAS 98(20): 11042-11046 (Sep. 25, 2001). cited by applicant . No Author. RSDSA, 2015: Telltale signs and symptoms of CRPS/RSD on the web at rsds.org/telltale-signs-and-symptoms-of-crpsrsd. [Accessed: Sep. 5, 2018]. cited by applicant . O'Keefe, Stephen J.D. et al. The Exacerbation of Pancreatic Endocrine Dysfunction by Potent Pancreatic Exocrine Supplements in Patients with Chronic Pancreatitis. J. Clin. Gastroenterol. 32(4):319-323 (2001). cited by applicant . Felig, P. Amino acid metabolism in man. Annual Review of Biochemistry, 44(1):933-955 (1975). [Abstract Only]. cited by applicant . Chez, M. et al. Secretin and autism: A two-part clinical investigation. Journal of Autism and Developmental Disorders, 30(2), 87-94 (Apr. 2000) [Abstract Only]. cited by applicant . Evans, C. et al. Altered amino acid excretion in children with autism. Nutritional Neuroscience, 11(1):9-17 (Feb. 2008) , Abstract Only. cited by applicant . Guesnet, P. et al. Docosahexaenoic acid (DHA) and the developing central nervous system (CNS)--Implications for dietary recommendations. Biochimie, 93(1):7-12(2011). [Abstract Only]. cited by applicant . Heil, M., et al. Low endogenous fecal chymotrypsin: a possible biomarker for autism. Poster presented at the annual IMFAR Conference on Autism, Atlanta, GA.(May 2014) p. 1. cited by applicant . Matthews, D. Intestinal absorption of amino acids and peptides. Proceedings of the Nutrition Society, 31(2):171-177(1972). cited by applicant . McClung, C.A. et al. DeltaFosB: A molecular switch for long-term adaptation in the brain. Molecular Brain Research, 132(2):146-154 (Dec. 20, 2004). cited by applicant . Morimoto, R. The heat shock response: Systems biology of proteotoxic stress in aging and disease. Cold Spring Harbor Symposia on Quantitative Biology, 76:91-99 (2011) (Epub: Feb. 27, 2012). cited by applicant . Munasinghe, S.A. et al. Digestive enzyme supplementation for autism spectrum disorders: A double-blind randomized controlled trial. Journal of Autism and Developmental Disorders, 40(9):1131-1138 (Sep. 2010) [Abstract Only]. cited by applicant . Naushad, Shaik Mohammad et al. Autistic children exhibit distinct plasma amino acid profile. Indian Journal of Biochemistry and Biophysics, 50(5):474-478 (Oct. 2013). cited by applicant . Patton, J. et al. Factor structure of the barratt impulsiveness scale. Journal of Clinical Psychology, 51(6): 768-774 (Nov. 1995). cited by applicant . Robinson, T. et al. Incentive-sensitization and addiction. Addiction, 96(1):103-114 (Jan. 2001). cited by applicant . Schedl, H. et al. Absorption of I-methionine from the human small intestine. Journal of Clinical Investigation, 47(2): 417-425 (1968). cited by applicant . Rivest, J. et al. A dynamic model of protein digestion in the small intestine of pigs. Journal of Animal Science, 78(2):328-240 (Feb. 2000). cited by applicant . Singh, Manjit. Alcoholic pancreatitis in rats fed ethanol in a nutritionally adequate liquid diet. International Journal of Pancreatology, 2:311-324 (1987). cited by applicant . Avruch, J., et al. Amino acid regulation of TOR complex 1. AJP: Endocrinology and Metabolism, Am. J. Physiol. Endocrinol. Metab. 296(4):E592-E602 (Apr. 2009). cited by applicant . Daly, E., et al. Response inhibition and serotonin in autism: A functional MRI study using acute tryptophan depletion. Brain, 137(9), 2600-2610 (Sep. 2014). cited by applicant . Drabkin, H., et al. Initiation of protein synthesis in mammalian cells with codons other than AUG and amino acids other than methionine. Molecular and Cellular Biology, 18(9): 5140-5147 (Sep. 1998). cited by applicant . Fairclough, P. et al. Comparison of the absorption of two protein hydrolysates and their effects on water and electrolyte movements in the human jejunum. Gut, 21(10):829-834 (1980). cited by applicant . McClung, C., et al. Regulation of gene expression and cocaine reward by CREB and DeltaFosB. Nature Neuroscience, 6(11):1208-1215 (2003). [Abstract Only]. cited by applicant . Nestler, E.J. Molecular basis of long-term plasticity underlying addiction. Nature Reviews Neuroscience, 2(2):119-128 (Feb. 2001). cited by applicant . Norton, L. et al. Leucine regulates translation initiation of protein synthesis in skeletal muscle after exercise. The Journal of Nutrition, 136(2):533S-537S (Feb. 2006). cited by applicant . Schain, RJ et al. Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. J. Pediatr. 58:315-320 (1961) [Summary Only]. cited by applicant . Tang, G. et al. Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits. Neuron, 83(5):1131-1143 (Sep. 3, 2014). cited by applicant . Williams, K. et al. Cochrane Review: Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD). Evidence-Based Child Health: A Cochrane Review Journal, 6(4):1044-1078 (Jul. 2011). [Abstract Only]. cited by applicant . U.S. Appl. No. 12/054,343 Non-Final Office Action dated Dec. 26, 2017. cited by applicant . U.S. Appl. No. 12/535,676 Non-Final Office Action dated Sep. 6, 2018. cited by applicant . U.S. Appl. No. 12/786,739 Final Office Action dated Sep. 25, 2018. cited by applicant . U.S. Appl. No. 12/786,739 Non-Final Office Action dated Jan. 4, 2018. cited by applicant . U.S. Appl. No. 13/002,136 Advisory Office Action dated Jul. 9, 2018. cited by applicant . U.S. Appl. No. 13/002,136 Final Office Action dated Jan. 8, 2018. cited by applicant . U.S. Appl. No. 13/733,873 Final Office Action dated Feb. 21, 2018. cited by applicant . U.S. Appl. No. 13/836,135 Non-Final Office Action dated Mar. 15, 2018. cited by applicant . U.S. Appl. No. 14/296,091 Final Office Action dated Oct. 1, 2018. cited by applicant . U.S. Appl. No. 14/296,091 Non-Final Office Action dated Mar. 22, 2018. cited by applicant . U.S. Appl. No. 14/612,580 Notice of Allowability dated Mar. 1, 2018. cited by applicant . U.S. Appl. No. 14/612,580 Notice of Allowance dated Jan. 12, 2018. cited by applicant . U.S. Appl. No. 14/713,242 Non-Final Office Action dated Mar. 29, 2018. cited by applicant . U.S. Appl. No. 14/921,896 Final Office Action dated Jan. 25, 2018. cited by applicant . U.S. Appl. No. 14/921,896 Notice of Allowability dated Sep. 12, 2018. cited by applicant . U.S. Appl. No. 14/921,896 Notice of Allowance dated Jul. 18, 2018. cited by applicant . U.S. Appl. No. 15/089,842 Non-Final Office Action dated Jun. 26, 2018. cited by applicant . U.S. Appl. No. 15/164,493 Non-Final Office Action dated Feb. 27, 2018. cited by applicant . U.S. Appl. No. 15/265,415 Non-Final Office Action dated Apr. 11, 2018. cited by applicant . U.S. Appl. No. 15/265,620 Non-Final Office Action dated Jun. 20, 2018. cited by applicant . U.S. Appl. No. 15/593,121 Non-Final Office Action dated Mar. 8, 2018. cited by applicant . Yang, Xinyi et al. Advances in anti-staphylococcal agent lysostaphin. Chinese Journal of New Drugs 14(9):1113-1117 (2005). cited by applicant . Bouhnik, et al. Lactulose ingestion increases faecal bifidobacterial counts: A randomized double-blind study in healthy humans. European Journal of Clinical Nutrition 58:462-466 (2004). cited by applicant . Chaignon et al. Susceptibility of staphylococcal biofilms to enzymatic treatments depends on their chemical compositions. Appl. Microbiol. Appl. Microbiol. 75:125-132 (2007). cited by applicant . Co-pending U.S. Appl. No. 15/593,121, filed May 11, 2017. cited by applicant . Co-pending U.S. Appl. No. 15/593,124, filed May 11, 2017. cited by applicant . Kidd, P.M., Autism, an extreme challenge to integrative medicine. Part 2: medical management. Altern. Med. Rev., 7(6):172-499 (Dec. 2002). cited by applicant . Marion et al., A New Procedure Allowing the Complete Removal and Prevention of Hemodialysis. Blood Purification, 23:339-348 (2005). cited by applicant . Neumeyer, Ann. M. et al. Brief Report: Bone Fractures in Children and Adults with Autism Spectrum Disorders. J. Autism Dev. Disord. 45(3):881-887 (Mar. 2016). cited by applicant . Proesmans, Marijke et al. Omeprazole, a proton pump inhibitor, improves residual steatorrhoea in cystic fibrosis patients treated with high dose pancreatic enzymes. European Journal of Pediatrics 162(11): 760-763 (Nov. 2003). cited by applicant . P. Ya. Grigoryev et al., Reference Guide on Gastroenterology, Moscow, MIA-2003, pp. 454,460,465. cited by applicant . Tuohy, K.M. et al. Using probiotics and prebiotics to improve gut health. Reviews, Therapeutic Focus, DDT 8(15) Aug. 2003. cited by applicant . U.S. Appl. No. 12/054,343 Final Office Action dated May 10, 2017. cited by applicant . U.S. Appl. No. 12/786,739 Final Office Action dated Jun. 23, 2017. cited by applicant . U.S. Appl. No. 13/503,844 Final Office Action dated Nov. 30, 2017. cited by applicant . U.S. Appl. No. 13/733,873 Non-Final Office Action dated May 25, 2017. cited by applicant . U.S. Appl. No. 13/757,412 Final Office Action dated Sep. 12, 2017. cited by applicant . U.S. Appl. No. 13/836,135 Final Office Action dated May 15, 2017. cited by applicant . U.S. Appl. No. 14/296,091 Final Office Action dated Aug. 23, 2017. cited by applicant . U.S. Appl. No. 14/612,580 Final Office Action dated Aug. 10, 2017. cited by applicant . U.S. Appl. No. 14/693,711 Notice of Allowability dated May 26, 2017. cited by applicant . U.S. Appl. No. 14/713,221 Notice of Allowance dated Oct. 19, 2017. cited by applicant . U.S. Appl. No. 14/713,242 Final Office Action dated Jul. 21, 2017. cited by applicant . U.S. Appl. No. 15/089,842 Office Action dated Dec. 8, 2017. cited by applicant . U.S. Appl. No. 15/185,511 Notice of Allowance dated Nov. 16, 2017. cited by applicant . Cox, RJ et al. Influenza Virus: Immunity and Vaccination Strategies. Comparison of the Immune Response to Inactivated and Live, Attenuated Influenza Vaccines. Scandinavian Journal of Immunology 59, 1-15 (2004). cited by applicant . U.S. Appl. No. 13/836,135 Final Office Action dated Dec. 14, 2018. cited by applicant . U.S. Appl. No. 15/089,842 Final Office Action dated Dec. 4, 2018. cited by applicant . U.S. Appl. No. 15/164,493 Notice of Allowance dated Nov. 15, 2018. cited by applicant . U.S. Appl. No. 15/354,940 Non-Final Office Action dated Nov. 2, 2018. cited by applicant . American Family Physician. Cuts, Scrapes, and Stitches. Am Fam Physician 69(11):2647-2648 (Jun. 1, 2004). cited by applicant . Carroccio et al. Effectiveness of Enteric-coated Preparations on Nutritional Parameters in Cystic Fibrosis. Digestion 41:201-206 (1988). cited by applicant . Carroccio et al. Role of pancreatic impairment in growth recovery during gluten-free diet in childhood celiac disease. Gastroenterology 112:1839-1844 (1997). cited by applicant . Cermak, Sharon A. et al. Food selectivity and sensory sensitivity in children with autism spectrum disorders. J. Am. Diet Assoc. 110(2):238-246 (Feb. 2010). cited by applicant . Chinese Patent Application No. 201380018617X Office Action dated Jun. 24, 2016. cited by applicant . Cichoke. Influenza. In: The Complete Book of Enzyme Therapy. Anthony J. Cichoke. Avery, a member of Penguin Putnam, Inc., publisher. Ed.: Dara Stewart, pp. 37, 40-45 (1999). cited by applicant . Cornish. A balanced approach towards healthy eating in autism, Journal of Human Nutrition and Dietetics 11:501-509 (1998). cited by applicant . Dudzinska. Dissertation. Development of lipid-based enteric coatings. Oct. 18, 1988. Martin Luther University, Halle-Wittenberg. pp. 1-125. cited by applicant . Durie et al. Uses and abuses of enzyme therapy in cystic fibrosis. Journal of the Royal Society of Medicine. 91:(Suppl. 34):2-13 (1998). cited by applicant . Flament, M.P. et al. Development of 400 .mu.m Pellets by Extrusion-Spheronization Applicaiton wiht Gelucire 50/02 to Produce a "Sprinkle" Form, Drug Development and industrial Pharmacy, 30:1, 43-51, DOI: 10.1081/DDC-120027510 (2004). cited by applicant . Ijuin, H. Evaluation of pancreatic exocrine function and zinc absorption in alcoholism. The Kurume Medical Journal 45.1 (1998): 1-5. cited by applicant . Johnson et al. Eating Habits and Dietary Status in Young Children with Autism. J Dev Phys Disabil 20:437-448 (2008). cited by applicant . Keller, et al. Pancreatic enzyme supplementation therapy. Current Treatment Options in Gastroenterology 6.5 (2003): 369-374. cited by applicant . Klopfleisch et al. Encephalitis in a stone marten (Martes foina) after natural infection with highly pathogenic avian influenza virus subtype H5N1. Journal of Comparative Pathology 137:155-159 (2007). cited by applicant . Koh et al. Inflammation and wound healing: The role of the macrophage. Expert Rev Mol Med. 13:e23 (Author manuscript), 2013. cited by applicant . Koivu et al. Determination of Phylloquinone in Vegetables, Fruits, and Berries by High-Performance Liquid Chromatography with Electrochemical Detection. J. Agric. Food Chem. 45(12):4644-4649 (1997). cited by applicant . Munesue, et al. High prevalence of bipolar disorder comorbidity in adolescents and young adults with high-functioning autism spectrum disorder: a preliminary study of 44 outpatients. Journal of Affective Disorders 111.2-3 (2008): 170-175. cited by applicant . Qi, et al. Solubility and emulsifying properties of soy protein isolates modified by pancreatin. Journal of Food Science 62.6 (1997): 1110-1115. cited by applicant . Salpekar, et al. Bipolar Spectrum Disorder Comorbid With Autism Spectrum Disorder; NADD Bulletin, vol. X, 2007. No. 6, Article 1, pp. 1-5, downloaded from http://www.thenadd.org/nadd-bulletin/archive/volunne-x/ on Dec. 11, 2018. cited by applicant . Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Primary Care Version, Chapter 6, American Psychiatric Association (2000). cited by applicant . Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision, DSM-IV-TR, American Psychiatric Association (2000). cited by applicant . U.S. Appl. No. 13/002,136 Non-Final Office Action dated Dec. 18, 2018. cited by applicant . U.S. Appl. No. 13/757,412 Office Action dated Apr. 16, 2019. cited by applicant . U.S. Appl. No. 13/836,135 Notice of Allowance dated Apr. 25, 2019. cited by applicant . U.S. Appl. No. 15/265,620 Non-Final Office Action dated Jan. 22, 2019. cited by applicant . U.S. Appl. No. 12/786,739 Office Action dated May 8, 2019. cited by applicant . U.S. Appl. No. 13/733,873 Office Action dated May 16, 2019. cited by applicant . U.S. Appl. No. 15/074,115 Office Action dated Mar. 6, 2019. cited by applicant . U.S. Appl. No. 15/089,842 Notice of Allowance dated Mar. 29, 2019. cited by applicant . U.S. Appl. No. 15/265,415 Notice of Allowance dated Dec. 26, 2018. cited by applicant . U.S. Appl. No. 15/593,121 Notice of Allowance dated Dec. 26, 2018. cited by applicant. |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.